BMPR1A
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A6ND36 | S610 | SIGNOR | FAM83G PAWS1 | LSDQDSHSGSSGRGPGPRRPsVAssVsEEyFEVREHSVPLR |
| A6ND36 | S614 | SIGNOR | FAM83G PAWS1 | DSHSGSSGRGPGPRRPsVAssVsEEyFEVREHSVPLRRRHs |
| A6ND36 | S616 | SIGNOR | FAM83G PAWS1 | HSGSSGRGPGPRRPsVAssVsEEyFEVREHSVPLRRRHsEQ |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O60231 | S107 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | ARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKH |
| O95394 | T62 | Sugiyama | PGM3 AGM1 | MGLLAVLRSKQTKSTIGVMVtAsHNPEEDNGVKLVDPLGEM |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P07195 | T18 | Sugiyama | LDHB | ___MATLKEKLIAPVAEEEAtVPNNKITVVGVGQVGMACAI |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07900 | S263 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P12956 | S560 | Sugiyama | XRCC6 G22P1 | VtKRKHDNEGSGSKRPKVEysEEELKTHISKGTLGKFTVPM |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P31947 | S37 | Sugiyama | SFN HME1 | ERyEDMAAFMKGAVEKGEELsCEERNLLsVAyKNVVGGQRA |
| P35579 | S1943 | Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P36894 | S205 | Sugiyama | BMPR1A ACVRLK3 ALK3 | SRRRYNRDLEQDEAFIPVGEsLKDLIDQsQssGsGSGLPLL |
| P36894 | S213 | Sugiyama | BMPR1A ACVRLK3 ALK3 | LEQDEAFIPVGEsLKDLIDQsQssGsGSGLPLLVQRTIAKQ |
| P36894 | S215 | Sugiyama | BMPR1A ACVRLK3 ALK3 | QDEAFIPVGEsLKDLIDQsQssGsGSGLPLLVQRTIAKQIQ |
| P36894 | S216 | Sugiyama | BMPR1A ACVRLK3 ALK3 | DEAFIPVGEsLKDLIDQsQssGsGSGLPLLVQRTIAKQIQM |
| P36894 | S218 | Sugiyama | BMPR1A ACVRLK3 ALK3 | AFIPVGEsLKDLIDQsQssGsGSGLPLLVQRTIAKQIQMVR |
| P36894 | S416 | Sugiyama | BMPR1A ACVRLK3 ALK3 | VPLNTRVGTKRYMAPEVLDEsLNKNHFQPYIMADIYSFGLI |
| P36894 | T391 | Sugiyama | BMPR1A ACVRLK3 ALK3 | KKNGSCCIADLGLAVKFNSDtNEVDVPLNTRVGTKRYMAPE |
| P49327 | S2198 | Sugiyama | FASN FAS | EVRQLTLRKLQELSSKADEAsELACPtPKEDGLAQQQtQLN |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P63104 | S37 | Sugiyama | YWHAZ | ERyDDMAACMKsVtEQGAELsNEERNLLsVAyKNVVGARRs |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13873 | S375 | Sugiyama | BMPR2 PPH1 | SMRLTGNRLVRPGEEDNAAIsEVGtIRYMAPEVLEGAVNLR |
| Q13873 | S680 | Sugiyama | BMPR2 PPH1 | EEDLETNKLDPKEVDKNLKEssDENLMEHsLKQFSGPDPLS |
| Q13873 | S689 | Sugiyama | BMPR2 PPH1 | DPKEVDKNLKEssDENLMEHsLKQFSGPDPLSSTSSSLLyP |
| Q13873 | T803 | Sugiyama | BMPR2 PPH1 | QVETGVAKMNtINAAEPHVVtVtMNGVAGRNHSVNsHAATt |
| Q13873 | T805 | Sugiyama | BMPR2 PPH1 | ETGVAKMNtINAAEPHVVtVtMNGVAGRNHSVNsHAATtQY |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15797 | S463 | SIGNOR | SMAD1 BSP1 MADH1 MADR1 | PLQWLDKVLTQMGsPHNPIssVs__________________ |
| Q15797 | S465 | SIGNOR | SMAD1 BSP1 MADH1 MADR1 | QWLDKVLTQMGsPHNPIssVs____________________ |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IWX8 | S822 | Sugiyama | CHERP DAN26 SCAF6 | SKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEE |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q99497 | S57 | Sugiyama | PARK7 | GLAGKDPVQCsRDVVICPDAsLEDAKKEGPyDVVVLPGGNL |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.907371e-09 | 8.536 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.819300e-08 | 7.235 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.450283e-07 | 6.073 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.517208e-07 | 6.186 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.588576e-06 | 5.066 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.911397e-06 | 5.102 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.269715e-05 | 4.644 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.071974e-05 | 4.513 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.487389e-05 | 4.457 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.661191e-05 | 4.062 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.717016e-05 | 4.012 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.880335e-04 | 3.726 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.297741e-04 | 3.639 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.895074e-04 | 3.538 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.778769e-04 | 3.423 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 3.811742e-04 | 3.419 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.688429e-04 | 3.245 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.641244e-04 | 3.249 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.235052e-04 | 3.141 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.824822e-04 | 3.166 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.241620e-04 | 3.140 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.398769e-04 | 3.076 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.328988e-04 | 3.079 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.249455e-03 | 2.903 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.249455e-03 | 2.903 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.278226e-03 | 2.893 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.281768e-03 | 2.892 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.409608e-03 | 2.851 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.999720e-03 | 2.699 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.186915e-03 | 2.660 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.422341e-03 | 2.616 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.756264e-03 | 2.560 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.756264e-03 | 2.560 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.057233e-03 | 2.515 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.117679e-03 | 2.506 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.383824e-03 | 2.471 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.534136e-03 | 2.452 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.801636e-03 | 2.420 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.225920e-03 | 2.374 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.225920e-03 | 2.374 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.367053e-03 | 2.360 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.716693e-03 | 2.326 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.836465e-03 | 2.315 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.680394e-03 | 2.246 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.680394e-03 | 2.246 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.368191e-03 | 2.196 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.598443e-03 | 2.181 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.041794e-03 | 2.152 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.735166e-03 | 2.112 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 8.360857e-03 | 2.078 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.997815e-03 | 2.000 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.068817e-02 | 1.971 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.195317e-02 | 1.923 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.163678e-02 | 1.934 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.300923e-02 | 1.886 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.819772e-02 | 1.740 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.819772e-02 | 1.740 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.819772e-02 | 1.740 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.819772e-02 | 1.740 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.434967e-02 | 1.843 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.534842e-02 | 1.814 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.610454e-02 | 1.793 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.798100e-02 | 1.745 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.436784e-02 | 1.843 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.706704e-02 | 1.768 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.610454e-02 | 1.793 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.756264e-02 | 1.755 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.751168e-02 | 1.757 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.021971e-02 | 1.694 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.911627e-02 | 1.719 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.053693e-02 | 1.687 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.247362e-02 | 1.648 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.176513e-02 | 1.662 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.175785e-02 | 1.662 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.205267e-02 | 1.657 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.226563e-02 | 1.652 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.260183e-02 | 1.646 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.432129e-02 | 1.614 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.363389e-02 | 1.626 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.351620e-02 | 1.629 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.451908e-02 | 1.610 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.543866e-02 | 1.595 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.750277e-02 | 1.561 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.750277e-02 | 1.561 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.697561e-02 | 1.569 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.750277e-02 | 1.561 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.822325e-02 | 1.549 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.841666e-02 | 1.546 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.961684e-02 | 1.528 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.145436e-02 | 1.502 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 3.831266e-02 | 1.417 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.831266e-02 | 1.417 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 3.587822e-02 | 1.445 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.901014e-02 | 1.409 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.793993e-02 | 1.421 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.793993e-02 | 1.421 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.901014e-02 | 1.409 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.853708e-02 | 1.414 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.587822e-02 | 1.445 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.539474e-02 | 1.451 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.539474e-02 | 1.451 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.370443e-02 | 1.472 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.926933e-02 | 1.406 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.944977e-02 | 1.404 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.062401e-02 | 1.391 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.062401e-02 | 1.391 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.118651e-02 | 1.385 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 4.976692e-02 | 1.303 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 4.976692e-02 | 1.303 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 4.976692e-02 | 1.303 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 4.976692e-02 | 1.303 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 4.976692e-02 | 1.303 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 4.976692e-02 | 1.303 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.045493e-02 | 1.297 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.253947e-02 | 1.371 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.977331e-02 | 1.303 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.297597e-02 | 1.367 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.297597e-02 | 1.367 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.737832e-02 | 1.324 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.253947e-02 | 1.371 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.045493e-02 | 1.297 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.534025e-02 | 1.344 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.571900e-02 | 1.340 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.563932e-02 | 1.341 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.692347e-02 | 1.329 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.045493e-02 | 1.297 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.115349e-02 | 1.291 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.756370e-02 | 1.240 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.756370e-02 | 1.240 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.692538e-02 | 1.245 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.692538e-02 | 1.245 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.160984e-02 | 1.287 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.627949e-02 | 1.250 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.265754e-02 | 1.279 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.206657e-02 | 1.283 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.403450e-02 | 1.267 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 5.160984e-02 | 1.287 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.627949e-02 | 1.250 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.203390e-02 | 1.284 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.284633e-02 | 1.277 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.705995e-02 | 1.013 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.705995e-02 | 1.013 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.705995e-02 | 1.013 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.705995e-02 | 1.013 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.705995e-02 | 1.013 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 9.705995e-02 | 1.013 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.705995e-02 | 1.013 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 1.420019e-01 | 0.848 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 1.420019e-01 | 0.848 | 0 | 0 |
| Defective SLC17A5 causes Salla disease (SD) and ISSD | R-HSA-5619035 | 1.420019e-01 | 0.848 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.420019e-01 | 0.848 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 1.420019e-01 | 0.848 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.847096e-01 | 0.734 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.847096e-01 | 0.734 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.811291e-02 | 1.107 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 9.334716e-02 | 1.030 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.334716e-02 | 1.030 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.334716e-02 | 1.030 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.334716e-02 | 1.030 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 2.252939e-01 | 0.647 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 2.252939e-01 | 0.647 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.252939e-01 | 0.647 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.252939e-01 | 0.647 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 2.252939e-01 | 0.647 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.093492e-01 | 0.961 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.260052e-01 | 0.900 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 2.638603e-01 | 0.579 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 2.638603e-01 | 0.579 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 7.473717e-02 | 1.126 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.432105e-01 | 0.844 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.005090e-01 | 0.522 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.005090e-01 | 0.522 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.303131e-02 | 1.200 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.303131e-02 | 1.200 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.788944e-01 | 0.747 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.258765e-01 | 0.900 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.972053e-01 | 0.705 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.972053e-01 | 0.705 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.353353e-01 | 0.475 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.353353e-01 | 0.475 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.353353e-01 | 0.475 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 9.068962e-02 | 1.042 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 9.068962e-02 | 1.042 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.632362e-02 | 1.178 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.837781e-02 | 1.007 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 9.837781e-02 | 1.007 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.837781e-02 | 1.007 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 9.837781e-02 | 1.007 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 9.837781e-02 | 1.007 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 9.837781e-02 | 1.007 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.169609e-02 | 1.145 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.146218e-01 | 0.941 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.684296e-01 | 0.434 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 3.684296e-01 | 0.434 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.684296e-01 | 0.434 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 3.684296e-01 | 0.434 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.684296e-01 | 0.434 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 3.684296e-01 | 0.434 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 9.547239e-02 | 1.020 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.531562e-01 | 0.597 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.531562e-01 | 0.597 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.531562e-01 | 0.597 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.531562e-01 | 0.597 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 2.531562e-01 | 0.597 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.989624e-01 | 0.701 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.989624e-01 | 0.701 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.719442e-01 | 0.566 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 3.998781e-01 | 0.398 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.998781e-01 | 0.398 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.543832e-02 | 1.020 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.127756e-01 | 0.948 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.794527e-01 | 0.746 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.452945e-01 | 0.838 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.386136e-01 | 0.622 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.386136e-01 | 0.622 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.094211e-01 | 0.509 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.297624e-01 | 0.367 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.297624e-01 | 0.367 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.381749e-01 | 0.860 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.280252e-01 | 0.484 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.280252e-01 | 0.484 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.464903e-01 | 0.460 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.581603e-01 | 0.339 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.581603e-01 | 0.339 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.104358e-01 | 0.957 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.128753e-01 | 0.672 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.647841e-01 | 0.438 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.647841e-01 | 0.438 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.647841e-01 | 0.438 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.647841e-01 | 0.438 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.851456e-01 | 0.314 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.851456e-01 | 0.314 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.498453e-01 | 0.602 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.498453e-01 | 0.602 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.084737e-01 | 0.681 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.084737e-01 | 0.681 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.007464e-01 | 0.397 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.007464e-01 | 0.397 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.785585e-01 | 0.555 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.183672e-01 | 0.378 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.357207e-01 | 0.361 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.668572e-01 | 0.436 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.527898e-01 | 0.344 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.695598e-01 | 0.328 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.567093e-01 | 0.340 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.567093e-01 | 0.340 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.567093e-01 | 0.340 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.697746e-01 | 0.432 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.024501e-01 | 0.395 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.114206e-01 | 0.386 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.826551e-01 | 0.316 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.559880e-01 | 0.341 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.467103e-01 | 0.350 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.467103e-01 | 0.350 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.959334e-01 | 0.708 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.490709e-01 | 0.827 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.490709e-01 | 0.827 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.041400e-01 | 0.982 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.041400e-01 | 0.982 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.960681e-02 | 1.048 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 9.547239e-02 | 1.020 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.252348e-01 | 0.647 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.611465e-01 | 0.793 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.063585e-01 | 0.973 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.794370e-01 | 0.554 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 2.156618e-01 | 0.666 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.041400e-01 | 0.982 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.718944e-01 | 0.566 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.547239e-02 | 1.020 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.169609e-02 | 1.145 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 9.547239e-02 | 1.020 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.788944e-01 | 0.747 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.794370e-01 | 0.554 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.870042e-01 | 0.542 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.790205e-01 | 0.747 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.851456e-01 | 0.314 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.077166e-01 | 0.512 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.675049e-01 | 0.573 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.005090e-01 | 0.522 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.169609e-02 | 1.145 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 8.919118e-02 | 1.050 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.209220e-01 | 0.656 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.851456e-01 | 0.314 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.851456e-01 | 0.314 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.554022e-01 | 0.449 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.559880e-01 | 0.341 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.729986e-02 | 1.112 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.007464e-01 | 0.397 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.177679e-02 | 1.087 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.242029e-01 | 0.649 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.638603e-01 | 0.579 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.388594e-02 | 1.027 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.157292e-01 | 0.666 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.611465e-01 | 0.793 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 3.280252e-01 | 0.484 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.209220e-01 | 0.656 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.851456e-01 | 0.314 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.250409e-01 | 0.648 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.013223e-02 | 1.096 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 3.464903e-01 | 0.460 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.828779e-01 | 0.417 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.739890e-01 | 0.759 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.972053e-01 | 0.705 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.386136e-01 | 0.622 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.108798e-01 | 0.676 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.781246e-01 | 0.556 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.896941e-01 | 0.409 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.695598e-01 | 0.328 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 2.794370e-01 | 0.554 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.996718e-01 | 0.700 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.103163e-01 | 0.677 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.304514e-01 | 0.637 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.919118e-02 | 1.050 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.911304e-01 | 0.536 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.119635e-02 | 1.148 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.589197e-02 | 1.181 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.608695e-01 | 0.794 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.005090e-01 | 0.522 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.319547e-01 | 0.880 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.719442e-01 | 0.566 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.719442e-01 | 0.566 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.998781e-01 | 0.398 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.694746e-01 | 0.771 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.209220e-01 | 0.656 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.581603e-01 | 0.339 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.647841e-01 | 0.438 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.647841e-01 | 0.438 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.652408e-01 | 0.782 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.695598e-01 | 0.328 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 3.675628e-01 | 0.435 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 4.203778e-01 | 0.376 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.470962e-01 | 0.350 | 0 | 0 |
| Translation | R-HSA-72766 | 3.619368e-01 | 0.441 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.386212e-01 | 0.470 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.562454e-01 | 0.591 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.959334e-01 | 0.708 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.381749e-01 | 0.860 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.381749e-01 | 0.860 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.381749e-01 | 0.860 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.381749e-01 | 0.860 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.736053e-01 | 0.325 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 7.473717e-02 | 1.126 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.577778e-01 | 0.802 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.665364e-01 | 0.331 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.462245e-01 | 0.350 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.203778e-01 | 0.376 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 3.353353e-01 | 0.475 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 3.684296e-01 | 0.434 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 3.684296e-01 | 0.434 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.735048e-01 | 0.761 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.190592e-01 | 0.924 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.581603e-01 | 0.339 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.593355e-01 | 0.586 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.610179e-01 | 0.583 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.183672e-01 | 0.378 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.168148e-01 | 0.380 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.302295e-01 | 0.366 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.975365e-01 | 0.401 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.011170e-01 | 0.397 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.057088e-01 | 0.392 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.861189e-01 | 0.730 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.252348e-01 | 0.647 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.190592e-01 | 0.924 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.665252e-01 | 0.436 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.077166e-01 | 0.512 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.380701e-01 | 0.358 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 1.260052e-01 | 0.900 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.452959e-01 | 0.462 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.359176e-01 | 0.627 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.309200e-01 | 0.637 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.148124e-01 | 0.940 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.311464e-01 | 0.636 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.882759e-01 | 0.540 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.356123e-01 | 0.628 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.420019e-01 | 0.848 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.252939e-01 | 0.647 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.260052e-01 | 0.900 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 2.638603e-01 | 0.579 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.638603e-01 | 0.579 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.473717e-02 | 1.126 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.432105e-01 | 0.844 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 3.005090e-01 | 0.522 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.946677e-02 | 1.158 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 1.788944e-01 | 0.747 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.972053e-01 | 0.705 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.353353e-01 | 0.475 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.353353e-01 | 0.475 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.353353e-01 | 0.475 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.157292e-01 | 0.666 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.531562e-01 | 0.597 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.659667e-02 | 1.177 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.999976e-02 | 1.046 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.989624e-01 | 0.701 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.375868e-01 | 0.861 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.094211e-01 | 0.509 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.297624e-01 | 0.367 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.280252e-01 | 0.484 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.657374e-01 | 0.576 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.303913e-01 | 0.885 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.794370e-01 | 0.554 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.464903e-01 | 0.460 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.581603e-01 | 0.339 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.290310e-01 | 0.889 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.851456e-01 | 0.314 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.851456e-01 | 0.314 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.346650e-01 | 0.475 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.007464e-01 | 0.397 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.484836e-01 | 0.458 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.668572e-01 | 0.436 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 4.527898e-01 | 0.344 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.009674e-02 | 1.045 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.291656e-01 | 0.889 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.632362e-02 | 1.178 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.280252e-01 | 0.484 | 0 | 0 |
| M Phase | R-HSA-68886 | 9.643094e-02 | 1.016 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.019723e-01 | 0.992 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.019723e-01 | 0.992 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.989624e-01 | 0.701 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.674075e-01 | 0.776 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.989624e-01 | 0.701 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.208328e-01 | 0.494 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.328699e-01 | 0.633 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.838086e-01 | 0.736 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.657374e-01 | 0.576 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.683914e-01 | 0.329 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 4.470962e-01 | 0.350 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.666489e-01 | 0.331 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.432292e-01 | 0.614 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.260052e-01 | 0.900 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.343996e-01 | 0.630 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 3.208328e-01 | 0.494 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.208328e-01 | 0.494 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.828779e-01 | 0.417 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.851456e-01 | 0.314 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.432292e-01 | 0.614 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.628369e-01 | 0.580 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.732271e-01 | 0.563 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.628369e-01 | 0.580 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.969722e-01 | 0.401 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.260052e-01 | 0.900 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.005090e-01 | 0.522 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.148124e-01 | 0.940 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.972053e-01 | 0.705 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.972053e-01 | 0.705 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.972053e-01 | 0.705 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.998781e-01 | 0.398 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.280252e-01 | 0.484 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.009152e-01 | 0.996 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.707730e-01 | 0.768 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.389126e-01 | 0.857 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.793536e-01 | 0.319 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.826551e-01 | 0.316 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.432579e-01 | 0.464 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.225537e-01 | 0.912 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.610179e-01 | 0.583 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.385202e-01 | 0.622 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.426698e-01 | 0.846 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.763902e-01 | 0.754 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.543832e-02 | 1.020 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.452875e-02 | 1.190 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.581603e-01 | 0.339 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.695598e-01 | 0.328 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.909353e-01 | 0.536 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.763902e-01 | 0.754 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.491711e-01 | 0.826 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.915025e-01 | 0.718 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.649757e-01 | 0.783 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.201415e-01 | 0.920 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.201415e-01 | 0.920 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.381749e-01 | 0.860 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 2.209220e-01 | 0.656 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 2.209220e-01 | 0.656 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.798168e-01 | 0.745 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.826551e-01 | 0.316 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.657374e-01 | 0.576 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.242029e-01 | 0.649 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.357207e-01 | 0.361 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.133067e-01 | 0.504 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.174992e-01 | 0.930 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.160009e-01 | 0.936 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.252939e-01 | 0.647 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.260052e-01 | 0.900 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 3.684296e-01 | 0.434 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.998781e-01 | 0.398 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.998781e-01 | 0.398 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.907141e-01 | 0.537 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.832223e-02 | 1.054 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.297624e-01 | 0.367 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.381749e-01 | 0.860 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.280252e-01 | 0.484 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.464903e-01 | 0.460 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.581603e-01 | 0.339 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 4.851456e-01 | 0.314 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.396696e-01 | 0.469 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.728044e-01 | 0.429 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.755035e-01 | 0.425 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.556304e-01 | 0.449 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.556392e-01 | 0.808 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.668572e-01 | 0.436 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.600043e-02 | 1.180 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.432105e-01 | 0.844 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.373051e-01 | 0.862 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.188869e-01 | 0.925 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.851456e-01 | 0.314 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.435312e-01 | 0.353 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.029253e-01 | 0.519 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.730205e-01 | 0.564 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.424365e-01 | 0.615 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.775597e-01 | 0.423 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.838086e-01 | 0.736 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.324978e-01 | 0.478 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 3.975365e-01 | 0.401 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.580566e-01 | 0.446 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.482170e-01 | 0.458 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.118432e-02 | 1.213 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.684296e-01 | 0.434 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.007464e-01 | 0.397 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.096695e-01 | 0.509 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.567093e-01 | 0.340 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.621697e-01 | 0.441 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.679615e-01 | 0.775 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.837569e-01 | 0.315 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.077166e-01 | 0.512 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 4.771534e-01 | 0.321 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.689092e-01 | 0.570 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.302295e-01 | 0.366 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.007464e-01 | 0.397 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.793536e-01 | 0.319 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.978770e-01 | 0.704 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.978770e-01 | 0.704 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.978770e-01 | 0.704 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.334716e-02 | 1.030 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.353353e-01 | 0.475 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.019723e-01 | 0.992 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.998781e-01 | 0.398 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.998781e-01 | 0.398 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.297624e-01 | 0.367 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.297624e-01 | 0.367 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.581603e-01 | 0.339 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.931997e-01 | 0.533 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.695598e-01 | 0.328 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.761743e-01 | 0.559 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 2.802319e-01 | 0.552 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.528042e-01 | 0.816 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.096695e-01 | 0.509 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.791484e-01 | 0.320 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.024501e-01 | 0.395 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 3.855101e-01 | 0.414 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.622618e-02 | 1.118 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.252348e-01 | 0.647 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.760136e-01 | 0.425 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 2.593355e-01 | 0.586 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.319547e-01 | 0.880 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.410019e-01 | 0.851 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.094211e-01 | 0.509 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.346650e-01 | 0.475 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 3.376171e-01 | 0.472 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.573462e-01 | 0.340 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.794370e-01 | 0.554 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.056856e-01 | 0.687 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.095468e-01 | 0.509 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.319374e-01 | 0.479 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.215991e-01 | 0.654 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.837462e-02 | 1.054 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.075040e-01 | 0.390 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 9.334716e-02 | 1.030 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.093492e-01 | 0.961 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 1.260052e-01 | 0.900 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.473717e-02 | 1.126 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.353353e-01 | 0.475 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.353353e-01 | 0.475 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.343996e-01 | 0.630 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 3.684296e-01 | 0.434 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.684296e-01 | 0.434 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.531562e-01 | 0.597 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.998781e-01 | 0.398 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.452945e-01 | 0.838 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.581603e-01 | 0.339 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.581603e-01 | 0.339 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.828779e-01 | 0.417 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.241578e-01 | 0.649 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.076425e-01 | 0.968 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 3.900166e-01 | 0.409 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.837462e-02 | 1.054 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.148124e-01 | 0.940 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.794527e-01 | 0.746 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.726278e-02 | 1.112 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.192360e-01 | 0.924 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.878723e-01 | 0.726 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.919118e-02 | 1.050 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.297624e-01 | 0.367 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.280252e-01 | 0.484 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.581603e-01 | 0.339 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.851456e-01 | 0.314 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.892852e-01 | 0.410 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.914945e-01 | 0.535 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.157505e-01 | 0.501 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.300662e-01 | 0.886 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.611465e-01 | 0.793 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.606102e-01 | 0.337 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.093492e-01 | 0.961 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.684296e-01 | 0.434 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.998610e-01 | 0.699 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.647841e-01 | 0.438 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.882759e-01 | 0.540 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.022950e-01 | 0.395 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.124719e-01 | 0.385 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.148397e-01 | 0.502 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.357207e-01 | 0.361 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.425332e-01 | 0.615 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.240170e-01 | 0.373 | 1 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 4.309247e-01 | 0.366 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.581603e-01 | 0.339 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.057088e-01 | 0.392 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.980535e-01 | 0.526 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.103163e-01 | 0.677 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.208328e-01 | 0.494 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.258765e-01 | 0.900 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.094211e-01 | 0.509 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.851456e-01 | 0.314 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.297624e-01 | 0.367 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.668572e-01 | 0.436 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.711626e-01 | 0.327 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.531562e-01 | 0.597 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.208328e-01 | 0.494 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.972053e-01 | 0.705 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.695598e-01 | 0.328 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.851456e-01 | 0.314 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.531562e-01 | 0.597 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.464903e-01 | 0.460 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.573462e-01 | 0.340 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.860182e-01 | 0.313 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.860182e-01 | 0.313 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.860182e-01 | 0.313 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.860182e-01 | 0.313 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.860182e-01 | 0.313 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.877059e-01 | 0.312 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.954052e-01 | 0.305 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.954052e-01 | 0.305 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.954052e-01 | 0.305 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.967492e-01 | 0.304 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.997124e-01 | 0.301 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.997124e-01 | 0.301 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.010051e-01 | 0.300 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.021545e-01 | 0.299 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.021545e-01 | 0.299 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 5.021545e-01 | 0.299 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.021545e-01 | 0.299 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.050699e-01 | 0.297 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.079962e-01 | 0.294 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.079962e-01 | 0.294 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.079962e-01 | 0.294 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.079962e-01 | 0.294 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.079962e-01 | 0.294 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.079962e-01 | 0.294 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.079962e-01 | 0.294 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.079962e-01 | 0.294 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.079962e-01 | 0.294 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.086607e-01 | 0.294 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.107885e-01 | 0.292 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.107885e-01 | 0.292 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.107885e-01 | 0.292 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.107885e-01 | 0.292 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.107885e-01 | 0.292 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.107885e-01 | 0.292 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.107885e-01 | 0.292 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.107885e-01 | 0.292 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.116830e-01 | 0.291 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.116830e-01 | 0.291 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.145068e-01 | 0.289 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.179600e-01 | 0.286 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.179600e-01 | 0.286 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.179600e-01 | 0.286 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.204209e-01 | 0.284 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.204209e-01 | 0.284 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.204209e-01 | 0.284 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.204209e-01 | 0.284 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.207840e-01 | 0.283 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.326731e-01 | 0.274 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.326731e-01 | 0.274 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.331509e-01 | 0.273 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.334275e-01 | 0.273 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.334275e-01 | 0.273 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.334275e-01 | 0.273 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.334275e-01 | 0.273 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.337862e-01 | 0.273 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.351557e-01 | 0.272 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.351557e-01 | 0.272 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.351557e-01 | 0.272 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.351557e-01 | 0.272 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.351557e-01 | 0.272 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.351557e-01 | 0.272 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.351557e-01 | 0.272 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.351557e-01 | 0.272 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.351557e-01 | 0.272 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.351557e-01 | 0.272 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.351557e-01 | 0.272 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 5.351557e-01 | 0.272 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.379050e-01 | 0.269 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.421883e-01 | 0.266 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 5.447468e-01 | 0.264 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.447468e-01 | 0.264 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.459264e-01 | 0.263 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.485515e-01 | 0.261 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.499316e-01 | 0.260 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.508222e-01 | 0.259 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.514650e-01 | 0.258 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.560790e-01 | 0.255 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.566369e-01 | 0.254 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.566369e-01 | 0.254 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.566369e-01 | 0.254 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.566369e-01 | 0.254 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.583106e-01 | 0.253 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.583106e-01 | 0.253 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.583106e-01 | 0.253 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.583106e-01 | 0.253 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.583106e-01 | 0.253 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.583106e-01 | 0.253 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.583106e-01 | 0.253 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.583106e-01 | 0.253 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.583106e-01 | 0.253 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.583106e-01 | 0.253 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.583106e-01 | 0.253 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.583106e-01 | 0.253 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.583106e-01 | 0.253 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.583106e-01 | 0.253 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.583106e-01 | 0.253 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.583106e-01 | 0.253 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.583106e-01 | 0.253 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.622645e-01 | 0.250 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.622645e-01 | 0.250 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.633279e-01 | 0.249 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.633279e-01 | 0.249 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.633279e-01 | 0.249 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.633279e-01 | 0.249 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.633279e-01 | 0.249 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.633983e-01 | 0.249 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.633983e-01 | 0.249 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.633983e-01 | 0.249 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.683389e-01 | 0.245 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 5.694235e-01 | 0.245 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.694235e-01 | 0.245 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.770155e-01 | 0.239 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.777538e-01 | 0.238 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 5.777538e-01 | 0.238 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.803134e-01 | 0.236 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 5.803134e-01 | 0.236 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.803134e-01 | 0.236 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.803134e-01 | 0.236 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.803134e-01 | 0.236 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.803134e-01 | 0.236 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.803134e-01 | 0.236 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.803134e-01 | 0.236 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.803134e-01 | 0.236 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.829462e-01 | 0.234 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.832269e-01 | 0.234 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.832269e-01 | 0.234 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.870039e-01 | 0.231 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.918274e-01 | 0.228 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.918274e-01 | 0.228 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.918274e-01 | 0.228 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.918274e-01 | 0.228 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.918274e-01 | 0.228 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.918274e-01 | 0.228 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.918274e-01 | 0.228 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.918274e-01 | 0.228 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.012214e-01 | 0.221 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.012214e-01 | 0.221 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.012214e-01 | 0.221 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.012214e-01 | 0.221 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.012214e-01 | 0.221 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.012214e-01 | 0.221 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.012214e-01 | 0.221 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.012214e-01 | 0.221 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.022784e-01 | 0.220 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.041864e-01 | 0.219 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.055480e-01 | 0.218 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 6.055480e-01 | 0.218 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 6.055480e-01 | 0.218 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.131927e-01 | 0.212 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.189159e-01 | 0.208 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.189159e-01 | 0.208 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.189159e-01 | 0.208 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.189159e-01 | 0.208 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.189159e-01 | 0.208 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.189159e-01 | 0.208 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.189159e-01 | 0.208 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.189159e-01 | 0.208 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.209539e-01 | 0.207 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.210890e-01 | 0.207 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.210890e-01 | 0.207 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.210890e-01 | 0.207 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 6.210890e-01 | 0.207 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.210890e-01 | 0.207 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 6.210890e-01 | 0.207 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.210890e-01 | 0.207 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.210890e-01 | 0.207 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.210890e-01 | 0.207 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.210890e-01 | 0.207 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.210890e-01 | 0.207 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 6.210890e-01 | 0.207 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.212738e-01 | 0.207 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.239038e-01 | 0.205 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.296037e-01 | 0.201 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.319322e-01 | 0.199 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.319322e-01 | 0.199 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.334707e-01 | 0.198 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.344101e-01 | 0.198 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.344101e-01 | 0.198 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 6.381717e-01 | 0.195 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.399680e-01 | 0.194 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.399680e-01 | 0.194 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.399680e-01 | 0.194 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.399680e-01 | 0.194 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.399680e-01 | 0.194 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.399680e-01 | 0.194 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.399680e-01 | 0.194 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.399680e-01 | 0.194 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.399680e-01 | 0.194 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 6.399680e-01 | 0.194 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.445986e-01 | 0.191 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.445986e-01 | 0.191 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.445986e-01 | 0.191 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.445986e-01 | 0.191 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.445986e-01 | 0.191 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.445986e-01 | 0.191 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.447102e-01 | 0.191 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.531889e-01 | 0.185 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.548034e-01 | 0.184 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.558128e-01 | 0.183 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.569178e-01 | 0.182 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.569178e-01 | 0.182 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.570581e-01 | 0.182 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.570581e-01 | 0.182 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.570581e-01 | 0.182 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.579074e-01 | 0.182 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.579074e-01 | 0.182 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.579074e-01 | 0.182 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.579074e-01 | 0.182 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.579074e-01 | 0.182 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.579074e-01 | 0.182 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.579074e-01 | 0.182 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.585157e-01 | 0.181 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.585157e-01 | 0.181 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.609689e-01 | 0.180 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.622695e-01 | 0.179 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.639910e-01 | 0.178 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.646892e-01 | 0.177 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.688928e-01 | 0.175 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.688928e-01 | 0.175 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.749539e-01 | 0.171 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.749539e-01 | 0.171 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 6.749539e-01 | 0.171 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.749539e-01 | 0.171 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.749539e-01 | 0.171 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.749539e-01 | 0.171 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.755274e-01 | 0.170 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.761869e-01 | 0.170 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.805274e-01 | 0.167 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.805274e-01 | 0.167 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.823581e-01 | 0.166 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.838382e-01 | 0.165 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.838382e-01 | 0.165 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.909441e-01 | 0.161 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.911521e-01 | 0.160 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 6.911521e-01 | 0.160 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 6.911521e-01 | 0.160 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.911521e-01 | 0.160 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.911521e-01 | 0.160 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.911521e-01 | 0.160 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.918258e-01 | 0.160 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 6.918258e-01 | 0.160 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 6.918258e-01 | 0.160 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.918258e-01 | 0.160 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 6.918258e-01 | 0.160 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.931021e-01 | 0.159 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.931021e-01 | 0.159 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.931021e-01 | 0.159 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.960865e-01 | 0.157 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.977541e-01 | 0.156 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.021598e-01 | 0.154 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.027925e-01 | 0.153 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.027925e-01 | 0.153 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.027925e-01 | 0.153 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.027925e-01 | 0.153 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.027925e-01 | 0.153 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.027925e-01 | 0.153 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.052364e-01 | 0.152 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.052364e-01 | 0.152 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.062345e-01 | 0.151 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.063203e-01 | 0.151 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.065439e-01 | 0.151 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.065439e-01 | 0.151 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.065439e-01 | 0.151 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.065439e-01 | 0.151 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.065439e-01 | 0.151 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.065439e-01 | 0.151 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.065439e-01 | 0.151 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.065439e-01 | 0.151 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.065439e-01 | 0.151 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.065439e-01 | 0.151 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.065439e-01 | 0.151 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.065439e-01 | 0.151 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.065439e-01 | 0.151 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 7.065439e-01 | 0.151 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.065439e-01 | 0.151 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.097293e-01 | 0.149 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.110123e-01 | 0.148 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.110123e-01 | 0.148 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 7.134326e-01 | 0.147 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.134326e-01 | 0.147 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.134326e-01 | 0.147 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.134326e-01 | 0.147 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.185980e-01 | 0.144 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.190614e-01 | 0.143 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.196609e-01 | 0.143 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 7.211695e-01 | 0.142 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.211695e-01 | 0.142 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.211695e-01 | 0.142 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.211695e-01 | 0.142 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 7.211695e-01 | 0.142 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.211695e-01 | 0.142 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.215226e-01 | 0.142 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 7.215507e-01 | 0.142 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.232664e-01 | 0.141 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.237514e-01 | 0.140 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.257986e-01 | 0.139 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.289032e-01 | 0.137 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.289433e-01 | 0.137 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.337544e-01 | 0.134 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.337544e-01 | 0.134 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.350671e-01 | 0.134 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.350671e-01 | 0.134 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.350671e-01 | 0.134 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.350671e-01 | 0.134 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.350671e-01 | 0.134 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.350671e-01 | 0.134 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.350671e-01 | 0.134 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.350671e-01 | 0.134 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.363521e-01 | 0.133 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.371110e-01 | 0.132 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 7.434474e-01 | 0.129 | 0 | 0 |
| Methylation | R-HSA-156581 | 7.434474e-01 | 0.129 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.434474e-01 | 0.129 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.434474e-01 | 0.129 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 7.443983e-01 | 0.128 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.454742e-01 | 0.128 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 7.482728e-01 | 0.126 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.482728e-01 | 0.126 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.528366e-01 | 0.123 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.528366e-01 | 0.123 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.599021e-01 | 0.119 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.602348e-01 | 0.119 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.604849e-01 | 0.119 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.608210e-01 | 0.119 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.608210e-01 | 0.119 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.608210e-01 | 0.119 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.608210e-01 | 0.119 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.608210e-01 | 0.119 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.619280e-01 | 0.118 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.619280e-01 | 0.118 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.619280e-01 | 0.118 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.619280e-01 | 0.118 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.619280e-01 | 0.118 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.619280e-01 | 0.118 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.619280e-01 | 0.118 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.619280e-01 | 0.118 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.637211e-01 | 0.117 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.673641e-01 | 0.115 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.673641e-01 | 0.115 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.707281e-01 | 0.113 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.707281e-01 | 0.113 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.725447e-01 | 0.112 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.727444e-01 | 0.112 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.727444e-01 | 0.112 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.727444e-01 | 0.112 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.730882e-01 | 0.112 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.746361e-01 | 0.111 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.792433e-01 | 0.108 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.817206e-01 | 0.107 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.828406e-01 | 0.106 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.840741e-01 | 0.106 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.840741e-01 | 0.106 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 7.874801e-01 | 0.104 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 7.874801e-01 | 0.104 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.885503e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.886204e-01 | 0.103 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.886204e-01 | 0.103 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.892271e-01 | 0.103 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 7.912136e-01 | 0.102 | 1 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.932734e-01 | 0.101 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.938926e-01 | 0.100 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.948396e-01 | 0.100 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.948396e-01 | 0.100 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.948396e-01 | 0.100 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.948396e-01 | 0.100 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 7.948396e-01 | 0.100 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.948396e-01 | 0.100 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 7.948396e-01 | 0.100 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.948396e-01 | 0.100 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.948986e-01 | 0.100 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.953798e-01 | 0.099 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.954450e-01 | 0.099 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.954450e-01 | 0.099 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.018770e-01 | 0.096 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.031448e-01 | 0.095 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.031448e-01 | 0.095 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.050690e-01 | 0.094 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.050690e-01 | 0.094 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.050690e-01 | 0.094 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.050690e-01 | 0.094 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.050690e-01 | 0.094 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.050690e-01 | 0.094 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.050690e-01 | 0.094 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 8.067113e-01 | 0.093 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.082395e-01 | 0.092 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.105859e-01 | 0.091 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.105859e-01 | 0.091 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.105859e-01 | 0.091 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.119689e-01 | 0.090 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.144288e-01 | 0.089 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.144288e-01 | 0.089 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.144288e-01 | 0.089 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.147889e-01 | 0.089 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.147889e-01 | 0.089 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.147889e-01 | 0.089 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.147889e-01 | 0.089 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.147889e-01 | 0.089 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.177752e-01 | 0.087 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.177752e-01 | 0.087 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.226909e-01 | 0.085 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.240248e-01 | 0.084 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.240248e-01 | 0.084 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.247191e-01 | 0.084 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.314242e-01 | 0.080 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.328006e-01 | 0.079 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.328006e-01 | 0.079 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.328006e-01 | 0.079 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.328006e-01 | 0.079 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.328006e-01 | 0.079 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.328006e-01 | 0.079 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.328006e-01 | 0.079 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.328006e-01 | 0.079 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.328006e-01 | 0.079 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 8.329030e-01 | 0.079 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 8.363178e-01 | 0.078 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.378971e-01 | 0.077 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.378971e-01 | 0.077 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.378971e-01 | 0.077 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.378971e-01 | 0.077 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.411322e-01 | 0.075 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.411322e-01 | 0.075 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.411322e-01 | 0.075 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.411392e-01 | 0.075 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.411392e-01 | 0.075 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.411392e-01 | 0.075 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.411392e-01 | 0.075 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.441443e-01 | 0.074 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.476372e-01 | 0.072 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.490625e-01 | 0.071 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.490625e-01 | 0.071 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.490625e-01 | 0.071 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.497797e-01 | 0.071 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.501721e-01 | 0.070 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.531652e-01 | 0.069 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.559869e-01 | 0.068 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.560199e-01 | 0.068 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.565911e-01 | 0.067 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.565911e-01 | 0.067 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.580816e-01 | 0.066 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.585718e-01 | 0.066 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.610613e-01 | 0.065 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.615949e-01 | 0.065 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.637445e-01 | 0.064 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.637445e-01 | 0.064 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.670023e-01 | 0.062 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.685479e-01 | 0.061 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.705416e-01 | 0.060 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 8.705416e-01 | 0.060 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.705416e-01 | 0.060 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.705416e-01 | 0.060 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.722151e-01 | 0.059 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.722151e-01 | 0.059 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.763317e-01 | 0.057 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.770000e-01 | 0.057 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.770000e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.770000e-01 | 0.057 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.770000e-01 | 0.057 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.770000e-01 | 0.057 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 8.770000e-01 | 0.057 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.770000e-01 | 0.057 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.770000e-01 | 0.057 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.770000e-01 | 0.057 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.770000e-01 | 0.057 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 8.770000e-01 | 0.057 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 8.770000e-01 | 0.057 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.770000e-01 | 0.057 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 8.772393e-01 | 0.057 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 8.772393e-01 | 0.057 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.772393e-01 | 0.057 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.772393e-01 | 0.057 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.803465e-01 | 0.055 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 8.805563e-01 | 0.055 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.805563e-01 | 0.055 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.820807e-01 | 0.054 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.831366e-01 | 0.054 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.831366e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.831366e-01 | 0.054 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.831366e-01 | 0.054 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.831366e-01 | 0.054 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.831366e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.831366e-01 | 0.054 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.831366e-01 | 0.054 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.831366e-01 | 0.054 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.889673e-01 | 0.051 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.889673e-01 | 0.051 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.889673e-01 | 0.051 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.889673e-01 | 0.051 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.889673e-01 | 0.051 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.912379e-01 | 0.050 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.912809e-01 | 0.050 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 8.945075e-01 | 0.048 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.945075e-01 | 0.048 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.945075e-01 | 0.048 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.945075e-01 | 0.048 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.945075e-01 | 0.048 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 8.955647e-01 | 0.048 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.961975e-01 | 0.048 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.997310e-01 | 0.046 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.997715e-01 | 0.046 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.997715e-01 | 0.046 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.998087e-01 | 0.046 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.003855e-01 | 0.046 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.003855e-01 | 0.046 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.021362e-01 | 0.045 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.022968e-01 | 0.045 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.022968e-01 | 0.045 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.022968e-01 | 0.045 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.025456e-01 | 0.045 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.047732e-01 | 0.043 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.047732e-01 | 0.043 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.047732e-01 | 0.043 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 9.047732e-01 | 0.043 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.051542e-01 | 0.043 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.076025e-01 | 0.042 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.081530e-01 | 0.042 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.095256e-01 | 0.041 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.095256e-01 | 0.041 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.101385e-01 | 0.041 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.113179e-01 | 0.040 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.113179e-01 | 0.040 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.113179e-01 | 0.040 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.120591e-01 | 0.040 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.132926e-01 | 0.039 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.140411e-01 | 0.039 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.140411e-01 | 0.039 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.158667e-01 | 0.038 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.183315e-01 | 0.037 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.183315e-01 | 0.037 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.183315e-01 | 0.037 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.183315e-01 | 0.037 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.183315e-01 | 0.037 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.183315e-01 | 0.037 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.183323e-01 | 0.037 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.183323e-01 | 0.037 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.195870e-01 | 0.036 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.220690e-01 | 0.035 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.221179e-01 | 0.035 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.224079e-01 | 0.035 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.224079e-01 | 0.035 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.224079e-01 | 0.035 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 9.248225e-01 | 0.034 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.248225e-01 | 0.034 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.262812e-01 | 0.033 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 9.262812e-01 | 0.033 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 9.275427e-01 | 0.033 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.282867e-01 | 0.032 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.299613e-01 | 0.032 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.299613e-01 | 0.032 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.299613e-01 | 0.032 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.299613e-01 | 0.032 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.299613e-01 | 0.032 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.308242e-01 | 0.031 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.311538e-01 | 0.031 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.326616e-01 | 0.030 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.334579e-01 | 0.030 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.334579e-01 | 0.030 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.334579e-01 | 0.030 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.336524e-01 | 0.030 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.336524e-01 | 0.030 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.363708e-01 | 0.029 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.367802e-01 | 0.028 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.377357e-01 | 0.028 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.397994e-01 | 0.027 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.429359e-01 | 0.026 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.429359e-01 | 0.026 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.429359e-01 | 0.026 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.439062e-01 | 0.025 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.440353e-01 | 0.025 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.440353e-01 | 0.025 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.456221e-01 | 0.024 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.462236e-01 | 0.024 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.471281e-01 | 0.024 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 9.484497e-01 | 0.023 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.484929e-01 | 0.023 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.505877e-01 | 0.022 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.510653e-01 | 0.022 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.510653e-01 | 0.022 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.510653e-01 | 0.022 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.510873e-01 | 0.022 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.518218e-01 | 0.021 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.531522e-01 | 0.021 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.535093e-01 | 0.021 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.542105e-01 | 0.020 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.557504e-01 | 0.020 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.557504e-01 | 0.020 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.558315e-01 | 0.020 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.558315e-01 | 0.020 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.558315e-01 | 0.020 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.601339e-01 | 0.018 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.601339e-01 | 0.018 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.601339e-01 | 0.018 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.601345e-01 | 0.018 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.608130e-01 | 0.017 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.621255e-01 | 0.017 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.621255e-01 | 0.017 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.623337e-01 | 0.017 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.640178e-01 | 0.016 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.663696e-01 | 0.015 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.663696e-01 | 0.015 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.663696e-01 | 0.015 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.667276e-01 | 0.015 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.675236e-01 | 0.014 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.691465e-01 | 0.014 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.706910e-01 | 0.013 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.727480e-01 | 0.012 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.729108e-01 | 0.012 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.735449e-01 | 0.012 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.751676e-01 | 0.011 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.751676e-01 | 0.011 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.761234e-01 | 0.010 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.766159e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.773170e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.782517e-01 | 0.010 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.784509e-01 | 0.009 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.784509e-01 | 0.009 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.791485e-01 | 0.009 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.795283e-01 | 0.009 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.803160e-01 | 0.009 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.810403e-01 | 0.008 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.817211e-01 | 0.008 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.824480e-01 | 0.008 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.828266e-01 | 0.008 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.832622e-01 | 0.007 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.833257e-01 | 0.007 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.833257e-01 | 0.007 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.833257e-01 | 0.007 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.837663e-01 | 0.007 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.843957e-01 | 0.007 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.850077e-01 | 0.007 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.853397e-01 | 0.006 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.857045e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.857045e-01 | 0.006 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.875080e-01 | 0.005 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.877235e-01 | 0.005 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.883573e-01 | 0.005 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.883573e-01 | 0.005 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.924789e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.926652e-01 | 0.003 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.926805e-01 | 0.003 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.929184e-01 | 0.003 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.937125e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.940101e-01 | 0.003 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.940273e-01 | 0.003 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.943808e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.949923e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.954365e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.956394e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.958315e-01 | 0.002 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.958315e-01 | 0.002 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.959702e-01 | 0.002 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.963423e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.964271e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.964703e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.965875e-01 | 0.001 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.978633e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.980722e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.981688e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.983761e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.986552e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.987867e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.987909e-01 | 0.001 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.990125e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.991220e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.991538e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.991963e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.993787e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.994223e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994297e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994297e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.994677e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995490e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.995684e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.997666e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.997777e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998054e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.998139e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998197e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.998744e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998933e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999204e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999312e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999447e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999638e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999684e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999704e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999765e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999895e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999910e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999933e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999977e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999989e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999989e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 6.208489e-08 | 7.207 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.054093e-07 | 6.392 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.290505e-06 | 5.889 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.306122e-06 | 5.136 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.754818e-05 | 4.560 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.872179e-05 | 4.542 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 5.471727e-05 | 4.262 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.864168e-05 | 4.163 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.783421e-05 | 4.109 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 7.783421e-05 | 4.109 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.199163e-05 | 4.086 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.739277e-05 | 4.011 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.086721e-04 | 3.964 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.072614e-04 | 3.970 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.255044e-04 | 3.901 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.241716e-04 | 3.906 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.436412e-04 | 3.843 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.941705e-04 | 3.712 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.744797e-04 | 3.427 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.930186e-04 | 3.406 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.080940e-04 | 3.216 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.080940e-04 | 3.216 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.210757e-04 | 3.207 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.210757e-04 | 3.207 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.210757e-04 | 3.207 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.566137e-04 | 3.254 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 6.368974e-04 | 3.196 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 7.885926e-04 | 3.103 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.124135e-04 | 3.090 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.124135e-04 | 3.090 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 9.609125e-04 | 3.017 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.020073e-03 | 2.991 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.017959e-03 | 2.992 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.070952e-03 | 2.970 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.203907e-03 | 2.919 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.164754e-03 | 2.934 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.166614e-03 | 2.933 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.203907e-03 | 2.919 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.245264e-03 | 2.905 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.411342e-03 | 2.850 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.546379e-03 | 2.811 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.629374e-03 | 2.788 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.629374e-03 | 2.788 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.727372e-03 | 2.763 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.863550e-03 | 2.730 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.321348e-03 | 2.634 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.300796e-03 | 2.638 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.458227e-03 | 2.609 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.481546e-03 | 2.605 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.657929e-03 | 2.575 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.866223e-03 | 2.543 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.007325e-03 | 2.522 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.044138e-03 | 2.517 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.168050e-03 | 2.499 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.168050e-03 | 2.499 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.441640e-03 | 2.463 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.550330e-03 | 2.450 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.533858e-03 | 2.452 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 3.523655e-03 | 2.453 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.790747e-03 | 2.421 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.868476e-03 | 2.412 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.043597e-03 | 2.393 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.099099e-03 | 2.387 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.176187e-03 | 2.379 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.416452e-03 | 2.355 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.863973e-03 | 2.313 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.108406e-03 | 2.292 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.108406e-03 | 2.292 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.350605e-03 | 2.272 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.456612e-03 | 2.263 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.564858e-03 | 2.255 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 5.905867e-03 | 2.229 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.154548e-03 | 2.211 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 6.243870e-03 | 2.205 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.333862e-03 | 2.198 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 6.345471e-03 | 2.198 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 7.081462e-03 | 2.150 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.649385e-03 | 2.116 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.748197e-03 | 2.111 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.082547e-02 | 1.966 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.082547e-02 | 1.966 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.082547e-02 | 1.966 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.082547e-02 | 1.966 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.058604e-02 | 1.975 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.480278e-03 | 2.023 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.480278e-03 | 2.023 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.480278e-03 | 2.023 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.172893e-03 | 2.037 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.480278e-03 | 2.023 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.006190e-02 | 1.997 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.006190e-02 | 1.997 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 9.426048e-03 | 2.026 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.184235e-03 | 2.037 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.191058e-02 | 1.924 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.191058e-02 | 1.924 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.202047e-02 | 1.920 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.226579e-02 | 1.911 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.216304e-02 | 1.915 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.203177e-02 | 1.920 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.253786e-02 | 1.902 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.264965e-02 | 1.898 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.339759e-02 | 1.873 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.347192e-02 | 1.871 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.517499e-02 | 1.819 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.449153e-02 | 1.839 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.527665e-02 | 1.816 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.553799e-02 | 1.809 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.681557e-02 | 1.774 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.658334e-02 | 1.780 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.672850e-02 | 1.777 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.657086e-02 | 1.781 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.731269e-02 | 1.762 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.696708e-02 | 1.770 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.681308e-02 | 1.774 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.837011e-02 | 1.736 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.839286e-02 | 1.735 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.935885e-02 | 1.713 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.943502e-02 | 1.711 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.963857e-02 | 1.707 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.975969e-02 | 1.704 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.175128e-02 | 1.663 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.175128e-02 | 1.663 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.175128e-02 | 1.663 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.175128e-02 | 1.663 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.175128e-02 | 1.663 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.175128e-02 | 1.663 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.096030e-02 | 1.679 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.034172e-02 | 1.692 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.034172e-02 | 1.692 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.075525e-02 | 1.683 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.184525e-02 | 1.661 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.188946e-02 | 1.660 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.188946e-02 | 1.660 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.318608e-02 | 1.635 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.489272e-02 | 1.604 | 1 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.490109e-02 | 1.604 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.490109e-02 | 1.604 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.594266e-02 | 1.586 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.860926e-02 | 1.543 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.860926e-02 | 1.543 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.698220e-02 | 1.569 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.860926e-02 | 1.543 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.612173e-02 | 1.583 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.869380e-02 | 1.542 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.961335e-02 | 1.529 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.042828e-02 | 1.517 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.042828e-02 | 1.517 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.103047e-02 | 1.508 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.103047e-02 | 1.508 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.145373e-02 | 1.502 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.205805e-02 | 1.494 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.554192e-02 | 1.449 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.567865e-02 | 1.448 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.482162e-02 | 1.458 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.642012e-02 | 1.439 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.371604e-02 | 1.472 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.689661e-02 | 1.433 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.691384e-02 | 1.433 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.741309e-02 | 1.427 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.762344e-02 | 1.425 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.800045e-02 | 1.420 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.928821e-02 | 1.406 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.014315e-02 | 1.396 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.093430e-02 | 1.388 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.124106e-02 | 1.385 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.216994e-02 | 1.375 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 4.549334e-02 | 1.342 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 4.549334e-02 | 1.342 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 4.549334e-02 | 1.342 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.544646e-02 | 1.342 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.544646e-02 | 1.342 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.664762e-02 | 1.331 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.515104e-02 | 1.345 | 0 | 0 |
| Protein folding | R-HSA-391251 | 4.396652e-02 | 1.357 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.544646e-02 | 1.342 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.549334e-02 | 1.342 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.788869e-02 | 1.320 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.797795e-02 | 1.319 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.806662e-02 | 1.318 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.130129e-02 | 1.290 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.140494e-02 | 1.289 | 1 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.144181e-02 | 1.289 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.178284e-02 | 1.286 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.218343e-02 | 1.282 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.296134e-02 | 1.276 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 6.069746e-02 | 1.217 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.069746e-02 | 1.217 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.078861e-02 | 1.216 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.374087e-02 | 1.270 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.744272e-02 | 1.241 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.557072e-02 | 1.255 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.653380e-02 | 1.248 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.977797e-02 | 1.223 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.628466e-02 | 1.250 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.992331e-02 | 1.222 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.557072e-02 | 1.255 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.557072e-02 | 1.255 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.354101e-02 | 1.271 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.597029e-02 | 1.252 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.688887e-02 | 1.245 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 6.104828e-02 | 1.214 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.204787e-02 | 1.207 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.260044e-02 | 1.203 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.260044e-02 | 1.203 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.376408e-02 | 1.195 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.376408e-02 | 1.195 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.416828e-02 | 1.193 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.570313e-02 | 1.182 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.596844e-02 | 1.181 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 6.706463e-02 | 1.174 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.723640e-02 | 1.172 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.752927e-02 | 1.171 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.836012e-02 | 1.165 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 6.854618e-02 | 1.164 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.856056e-02 | 1.164 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.523522e-02 | 1.124 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 8.229441e-02 | 1.085 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.598647e-02 | 1.119 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.598647e-02 | 1.119 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 7.688368e-02 | 1.114 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.389607e-02 | 1.131 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 7.598647e-02 | 1.119 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.753052e-02 | 1.111 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 8.229441e-02 | 1.085 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.065410e-02 | 1.093 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.708974e-02 | 1.113 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 8.045510e-02 | 1.094 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.523522e-02 | 1.124 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.223658e-02 | 1.085 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.150828e-02 | 1.146 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.150828e-02 | 1.146 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.142447e-02 | 1.089 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 8.229441e-02 | 1.085 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.598647e-02 | 1.119 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.580221e-02 | 1.067 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 8.712805e-02 | 1.060 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.720135e-02 | 1.059 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.720135e-02 | 1.059 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.760520e-02 | 1.057 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.799835e-02 | 1.056 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 9.068217e-02 | 1.042 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 9.068217e-02 | 1.042 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.088117e-02 | 1.042 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.271551e-02 | 1.033 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.529949e-02 | 1.021 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.062622e-01 | 0.974 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.094351e-01 | 0.961 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.042836e-01 | 0.982 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.042836e-01 | 0.982 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.042836e-01 | 0.982 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.042836e-01 | 0.982 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.081998e-01 | 0.966 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.081998e-01 | 0.966 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.081998e-01 | 0.966 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.081998e-01 | 0.966 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.049052e-01 | 0.979 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.049052e-01 | 0.979 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.115203e-01 | 0.953 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.150986e-01 | 0.939 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.121034e-01 | 0.950 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.081998e-01 | 0.966 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.081998e-01 | 0.966 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.036840e-01 | 0.984 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.093304e-01 | 0.961 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.016721e-01 | 0.993 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.071057e-01 | 0.970 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.094351e-01 | 0.961 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.119225e-01 | 0.951 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.000239e-01 | 1.000 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.150986e-01 | 0.939 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.042836e-01 | 0.982 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.730810e-02 | 1.012 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 1.042836e-01 | 0.982 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.000724e-01 | 1.000 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 1.034709e-01 | 0.985 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.000724e-01 | 1.000 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.155016e-01 | 0.937 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.160048e-01 | 0.936 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.160048e-01 | 0.936 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.160048e-01 | 0.936 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.178080e-01 | 0.929 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.012383e-01 | 0.696 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.012383e-01 | 0.696 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.012383e-01 | 0.696 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.012383e-01 | 0.696 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.012383e-01 | 0.696 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.012383e-01 | 0.696 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.468109e-01 | 0.833 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.468109e-01 | 0.833 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 2.861264e-01 | 0.543 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.861264e-01 | 0.543 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 2.861264e-01 | 0.543 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.861264e-01 | 0.543 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.861264e-01 | 0.543 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.861264e-01 | 0.543 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.861264e-01 | 0.543 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.861264e-01 | 0.543 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.863022e-01 | 0.730 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 1.863022e-01 | 0.730 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.282946e-01 | 0.892 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.282946e-01 | 0.892 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.282946e-01 | 0.892 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.540400e-01 | 0.812 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.540400e-01 | 0.812 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.540400e-01 | 0.812 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.540400e-01 | 0.812 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.540400e-01 | 0.812 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.270381e-01 | 0.644 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.270381e-01 | 0.644 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.270381e-01 | 0.644 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.270381e-01 | 0.644 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.270381e-01 | 0.644 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.619975e-01 | 0.441 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.619975e-01 | 0.441 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.619975e-01 | 0.441 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.619975e-01 | 0.441 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.619975e-01 | 0.441 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.619975e-01 | 0.441 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.619975e-01 | 0.441 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.619975e-01 | 0.441 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.619975e-01 | 0.441 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.268737e-01 | 0.897 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.683086e-01 | 0.571 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.201542e-01 | 0.920 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 2.095764e-01 | 0.679 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.678174e-01 | 0.775 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.678174e-01 | 0.775 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.255267e-01 | 0.901 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.898306e-01 | 0.722 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.095406e-01 | 0.509 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.095406e-01 | 0.509 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.298090e-01 | 0.367 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.298090e-01 | 0.367 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.298090e-01 | 0.367 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.298090e-01 | 0.367 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.298090e-01 | 0.367 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.298090e-01 | 0.367 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.298090e-01 | 0.367 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.298090e-01 | 0.367 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 4.298090e-01 | 0.367 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.298090e-01 | 0.367 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.298090e-01 | 0.367 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.298090e-01 | 0.367 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 1.398928e-01 | 0.854 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 1.398928e-01 | 0.854 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 1.398928e-01 | 0.854 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.714700e-01 | 0.766 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.714700e-01 | 0.766 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.126920e-01 | 0.672 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.686636e-01 | 0.571 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.686636e-01 | 0.571 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.686636e-01 | 0.571 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.686636e-01 | 0.571 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.686636e-01 | 0.571 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.902015e-01 | 0.721 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.902015e-01 | 0.721 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.502763e-01 | 0.456 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 2.989046e-01 | 0.524 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.989046e-01 | 0.524 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 2.989046e-01 | 0.524 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.678872e-01 | 0.775 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.041364e-01 | 0.690 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.041364e-01 | 0.690 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.639071e-01 | 0.785 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.437855e-01 | 0.842 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.593431e-01 | 0.798 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.593431e-01 | 0.798 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.293106e-01 | 0.482 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 3.293106e-01 | 0.482 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.901558e-01 | 0.409 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.901558e-01 | 0.409 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.901558e-01 | 0.409 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.904165e-01 | 0.309 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.904165e-01 | 0.309 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.904165e-01 | 0.309 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.904165e-01 | 0.309 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.904165e-01 | 0.309 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.904165e-01 | 0.309 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.904165e-01 | 0.309 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.904165e-01 | 0.309 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.838817e-01 | 0.735 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.099173e-01 | 0.509 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.580372e-01 | 0.588 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.596828e-01 | 0.444 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.596828e-01 | 0.444 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.596828e-01 | 0.444 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.925015e-01 | 0.534 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.378989e-01 | 0.860 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.767997e-01 | 0.558 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.767997e-01 | 0.558 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.289012e-01 | 0.368 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.289012e-01 | 0.368 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.625327e-01 | 0.581 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.141125e-01 | 0.503 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.141125e-01 | 0.503 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.141125e-01 | 0.503 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.301042e-01 | 0.886 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.482764e-01 | 0.829 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.425455e-01 | 0.846 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.628445e-01 | 0.788 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 2.958643e-01 | 0.529 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.898441e-01 | 0.409 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.796276e-01 | 0.553 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.796276e-01 | 0.553 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.796276e-01 | 0.553 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.716508e-01 | 0.765 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.602034e-01 | 0.443 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.602034e-01 | 0.443 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.516380e-01 | 0.599 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.516380e-01 | 0.599 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.359182e-01 | 0.474 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.359182e-01 | 0.474 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.359182e-01 | 0.474 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.346718e-01 | 0.475 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.578419e-01 | 0.446 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.578419e-01 | 0.446 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.196383e-01 | 0.377 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.445850e-01 | 0.264 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.445850e-01 | 0.264 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.445850e-01 | 0.264 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.445850e-01 | 0.264 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.445850e-01 | 0.264 | 0 | 0 |
| Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA) | R-HSA-5619067 | 5.445850e-01 | 0.264 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.445850e-01 | 0.264 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 3.323365e-01 | 0.478 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.543027e-01 | 0.451 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.798102e-01 | 0.420 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.798102e-01 | 0.420 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.373733e-01 | 0.625 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.373733e-01 | 0.625 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.261479e-01 | 0.487 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.489297e-01 | 0.348 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 3.055989e-01 | 0.515 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.017531e-01 | 0.396 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.017531e-01 | 0.396 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.966758e-01 | 0.528 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.155758e-01 | 0.501 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.351882e-01 | 0.361 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.022095e-01 | 0.299 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.022095e-01 | 0.299 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.517964e-01 | 0.454 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.134640e-01 | 0.384 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.776021e-01 | 0.321 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.776021e-01 | 0.321 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.043667e-01 | 0.393 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.453036e-01 | 0.351 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.526358e-01 | 0.344 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.667926e-01 | 0.331 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.055577e-01 | 0.296 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.055577e-01 | 0.296 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.365158e-01 | 0.270 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.929983e-01 | 0.227 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.929983e-01 | 0.227 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.929983e-01 | 0.227 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.929983e-01 | 0.227 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.056364e-01 | 0.392 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.327153e-01 | 0.274 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.327153e-01 | 0.274 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.327153e-01 | 0.274 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.327153e-01 | 0.274 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.327153e-01 | 0.274 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.691565e-01 | 0.245 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.691565e-01 | 0.245 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.691565e-01 | 0.245 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.590099e-01 | 0.253 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.022705e-01 | 0.299 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 5.753458e-01 | 0.240 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.753458e-01 | 0.240 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.843903e-01 | 0.233 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.886908e-01 | 0.230 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.395268e-01 | 0.621 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.263062e-01 | 0.645 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 2.096186e-01 | 0.679 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.543027e-01 | 0.451 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.271921e-01 | 0.896 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.537994e-01 | 0.813 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.533101e-01 | 0.257 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.017531e-01 | 0.396 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.925015e-01 | 0.534 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.868563e-01 | 0.313 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.407500e-01 | 0.618 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 2.686636e-01 | 0.571 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.421912e-01 | 0.266 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.837072e-01 | 0.234 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.862940e-01 | 0.413 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.714082e-01 | 0.766 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.032057e-01 | 0.298 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.477045e-01 | 0.831 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.216487e-01 | 0.654 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.989046e-01 | 0.524 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.371930e-01 | 0.472 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.902015e-01 | 0.721 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.216487e-01 | 0.654 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.170664e-01 | 0.286 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.282946e-01 | 0.892 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.616758e-01 | 0.791 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.967835e-01 | 0.528 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 3.323365e-01 | 0.478 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.838167e-01 | 0.315 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.688976e-01 | 0.329 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.872466e-01 | 0.231 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 5.429769e-01 | 0.265 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.887808e-01 | 0.311 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.201542e-01 | 0.920 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.969884e-01 | 0.527 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.428068e-01 | 0.354 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.544910e-01 | 0.811 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.770455e-01 | 0.752 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.058269e-01 | 0.686 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 5.590099e-01 | 0.253 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.190958e-01 | 0.659 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.812291e-01 | 0.742 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.678174e-01 | 0.775 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.901558e-01 | 0.409 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.596828e-01 | 0.444 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.141125e-01 | 0.503 | 1 | 1 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.126920e-01 | 0.672 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.700547e-01 | 0.328 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.880189e-01 | 0.312 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.282946e-01 | 0.892 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.095406e-01 | 0.509 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.095406e-01 | 0.509 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.096186e-01 | 0.679 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 3.901558e-01 | 0.409 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.289012e-01 | 0.368 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.677572e-01 | 0.775 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.967835e-01 | 0.528 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.190958e-01 | 0.659 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.667926e-01 | 0.331 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.707512e-01 | 0.768 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.151739e-01 | 0.501 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.130097e-01 | 0.504 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.502390e-01 | 0.456 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.268266e-01 | 0.644 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.502763e-01 | 0.456 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.501832e-01 | 0.602 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.958643e-01 | 0.529 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.623395e-01 | 0.581 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.569799e-01 | 0.590 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.606842e-01 | 0.584 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.866600e-01 | 0.232 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 1.255267e-01 | 0.901 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.535027e-01 | 0.814 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.989046e-01 | 0.524 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.901558e-01 | 0.409 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.904165e-01 | 0.309 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.396345e-01 | 0.620 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.767997e-01 | 0.558 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.796276e-01 | 0.553 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.445850e-01 | 0.264 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 5.022095e-01 | 0.299 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.055577e-01 | 0.296 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.055577e-01 | 0.296 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.365158e-01 | 0.270 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 5.294964e-01 | 0.276 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.663031e-01 | 0.331 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.286209e-01 | 0.641 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 2.362651e-01 | 0.627 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.798102e-01 | 0.420 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.838817e-01 | 0.735 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.812291e-01 | 0.742 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.388074e-01 | 0.622 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.707512e-01 | 0.768 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.596910e-01 | 0.338 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.353359e-01 | 0.361 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.175493e-01 | 0.662 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.770455e-01 | 0.752 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.533101e-01 | 0.257 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.108936e-01 | 0.386 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.511065e-01 | 0.455 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.863022e-01 | 0.730 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.282946e-01 | 0.892 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 1.540400e-01 | 0.812 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 2.683086e-01 | 0.571 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.201542e-01 | 0.920 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 3.095406e-01 | 0.509 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.686636e-01 | 0.571 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.049052e-01 | 0.688 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 5.445850e-01 | 0.264 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 5.445850e-01 | 0.264 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.445850e-01 | 0.264 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.445850e-01 | 0.264 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 4.489297e-01 | 0.348 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.884001e-01 | 0.411 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.744998e-01 | 0.427 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.929983e-01 | 0.227 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.327153e-01 | 0.274 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.590099e-01 | 0.253 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.471556e-01 | 0.262 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.371930e-01 | 0.472 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.399266e-01 | 0.854 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.938738e-01 | 0.405 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.921892e-01 | 0.534 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.224183e-01 | 0.374 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 2.784111e-01 | 0.555 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.992583e-01 | 0.302 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 3.151739e-01 | 0.501 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.404514e-01 | 0.356 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 2.062733e-01 | 0.686 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.437855e-01 | 0.842 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 3.596828e-01 | 0.444 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.952607e-01 | 0.709 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.280625e-01 | 0.642 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.729322e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.128363e-01 | 0.384 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.088457e-01 | 0.680 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.957414e-01 | 0.529 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.911782e-01 | 0.309 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.958273e-01 | 0.305 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.958273e-01 | 0.305 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.958273e-01 | 0.305 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.958273e-01 | 0.305 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.268737e-01 | 0.897 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.144426e-01 | 0.289 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.976571e-01 | 0.704 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.270381e-01 | 0.644 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.298090e-01 | 0.367 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.445850e-01 | 0.264 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.103826e-01 | 0.387 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.884001e-01 | 0.411 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.929983e-01 | 0.227 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.074992e-01 | 0.295 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.327153e-01 | 0.274 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.838817e-01 | 0.735 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.578419e-01 | 0.446 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.502763e-01 | 0.456 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 2.494737e-01 | 0.603 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.563347e-01 | 0.806 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.372103e-01 | 0.863 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.377667e-01 | 0.861 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.355516e-01 | 0.868 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.716932e-01 | 0.243 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.683086e-01 | 0.571 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.293109e-01 | 0.640 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.590099e-01 | 0.253 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.281314e-01 | 0.277 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.149362e-01 | 0.502 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.976571e-01 | 0.704 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.527288e-01 | 0.597 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.901558e-01 | 0.409 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.049052e-01 | 0.688 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.159459e-01 | 0.666 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.317512e-01 | 0.635 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.257311e-01 | 0.279 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.351882e-01 | 0.361 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 5.055577e-01 | 0.296 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.359182e-01 | 0.474 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.602034e-01 | 0.443 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.466613e-01 | 0.460 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 1.477045e-01 | 0.831 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.818685e-01 | 0.740 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.132677e-01 | 0.671 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.280183e-01 | 0.277 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.032057e-01 | 0.298 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.032057e-01 | 0.298 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.295777e-01 | 0.887 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.178270e-01 | 0.498 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.012383e-01 | 0.696 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.861264e-01 | 0.543 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.861264e-01 | 0.543 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.540400e-01 | 0.812 | 0 | 0 |
| Proton/oligopeptide cotransporters | R-HSA-427975 | 2.270381e-01 | 0.644 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.619975e-01 | 0.441 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.619975e-01 | 0.441 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.467879e-01 | 0.833 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.683086e-01 | 0.571 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.201542e-01 | 0.920 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.095764e-01 | 0.679 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.898306e-01 | 0.722 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.095406e-01 | 0.509 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.298090e-01 | 0.367 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.686636e-01 | 0.571 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.502763e-01 | 0.456 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.871529e-01 | 0.728 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.904165e-01 | 0.309 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.396345e-01 | 0.620 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.289012e-01 | 0.368 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.625327e-01 | 0.581 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.374448e-01 | 0.624 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.151739e-01 | 0.501 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.445850e-01 | 0.264 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.502390e-01 | 0.456 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.489297e-01 | 0.348 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.055989e-01 | 0.515 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.937498e-01 | 0.405 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.776021e-01 | 0.321 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.549062e-01 | 0.450 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.884001e-01 | 0.411 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.838167e-01 | 0.315 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.365158e-01 | 0.270 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.929983e-01 | 0.227 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.691565e-01 | 0.245 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.086385e-01 | 0.389 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.305070e-01 | 0.884 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.771294e-01 | 0.752 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.824903e-01 | 0.549 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.978443e-01 | 0.526 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.944892e-01 | 0.531 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.675348e-01 | 0.330 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.305509e-01 | 0.366 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.729613e-01 | 0.325 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.374448e-01 | 0.624 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 4.720058e-01 | 0.326 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.402866e-01 | 0.853 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 5.533101e-01 | 0.257 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 3.596828e-01 | 0.444 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.309001e-01 | 0.883 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.280287e-01 | 0.277 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.528140e-01 | 0.816 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.191602e-01 | 0.496 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 5.055577e-01 | 0.296 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.909168e-01 | 0.719 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.100789e-01 | 0.509 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.752803e-01 | 0.756 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.331077e-01 | 0.363 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.969731e-01 | 0.401 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.393843e-01 | 0.621 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.812291e-01 | 0.742 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 1.255267e-01 | 0.901 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.495240e-01 | 0.825 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.099173e-01 | 0.509 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 2.580372e-01 | 0.588 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.196383e-01 | 0.377 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.905537e-01 | 0.408 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.632591e-01 | 0.580 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.898441e-01 | 0.409 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.602034e-01 | 0.443 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.583142e-01 | 0.339 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.142167e-01 | 0.383 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.327153e-01 | 0.274 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.533101e-01 | 0.257 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.711645e-01 | 0.567 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.328540e-01 | 0.478 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.268737e-01 | 0.897 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.683086e-01 | 0.571 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.901558e-01 | 0.409 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.289012e-01 | 0.368 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.309001e-01 | 0.883 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.937498e-01 | 0.405 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.022095e-01 | 0.299 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 3.727240e-01 | 0.429 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.667926e-01 | 0.331 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.929983e-01 | 0.227 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.590099e-01 | 0.253 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.783877e-01 | 0.238 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.911782e-01 | 0.309 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.521248e-01 | 0.345 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.715112e-01 | 0.566 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.771765e-01 | 0.557 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.287855e-01 | 0.277 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.216487e-01 | 0.654 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.067675e-01 | 0.685 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.162340e-01 | 0.500 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.055577e-01 | 0.296 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.453601e-01 | 0.462 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.678872e-01 | 0.775 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.812291e-01 | 0.742 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.843903e-01 | 0.233 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.801334e-01 | 0.553 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.700491e-01 | 0.244 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.055577e-01 | 0.296 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.753458e-01 | 0.240 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 4.489297e-01 | 0.348 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.691565e-01 | 0.245 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.287855e-01 | 0.277 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.053539e-01 | 0.296 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.914910e-01 | 0.228 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.145722e-01 | 0.502 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.884009e-01 | 0.725 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.439989e-01 | 0.264 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.439989e-01 | 0.264 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.270381e-01 | 0.644 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.388074e-01 | 0.622 | 0 | 0 |
| SLC-mediated transport of oligopeptides | R-HSA-9959399 | 3.095406e-01 | 0.509 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.298090e-01 | 0.367 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.298090e-01 | 0.367 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 2.686636e-01 | 0.571 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.537994e-01 | 0.813 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.901558e-01 | 0.409 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.904165e-01 | 0.309 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.904165e-01 | 0.309 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.904165e-01 | 0.309 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.767997e-01 | 0.558 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.625327e-01 | 0.581 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.151739e-01 | 0.501 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.776021e-01 | 0.321 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.929983e-01 | 0.227 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.729322e-01 | 0.325 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.958273e-01 | 0.305 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.796276e-01 | 0.553 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.083914e-01 | 0.389 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.111438e-01 | 0.291 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.880189e-01 | 0.312 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.649822e-01 | 0.577 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.608844e-01 | 0.443 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.327153e-01 | 0.274 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.111438e-01 | 0.291 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.967835e-01 | 0.528 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.723079e-01 | 0.242 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.683086e-01 | 0.571 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.502763e-01 | 0.456 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.346718e-01 | 0.475 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.517964e-01 | 0.454 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.809454e-01 | 0.419 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.880189e-01 | 0.312 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.694067e-01 | 0.245 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.453036e-01 | 0.351 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.969884e-01 | 0.527 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 5.886908e-01 | 0.230 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.280183e-01 | 0.277 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 3.689584e-01 | 0.433 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.743594e-01 | 0.241 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.055577e-01 | 0.296 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.886908e-01 | 0.230 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.043667e-01 | 0.393 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.801334e-01 | 0.553 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.785004e-01 | 0.238 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.282946e-01 | 0.892 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.619975e-01 | 0.441 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.619975e-01 | 0.441 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.298090e-01 | 0.367 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.126920e-01 | 0.672 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.904165e-01 | 0.309 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.289012e-01 | 0.368 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.625327e-01 | 0.581 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.445850e-01 | 0.264 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.445850e-01 | 0.264 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.885729e-01 | 0.411 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.929983e-01 | 0.227 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.043667e-01 | 0.393 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.057126e-01 | 0.515 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.132677e-01 | 0.671 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.596910e-01 | 0.338 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.137021e-01 | 0.289 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.287855e-01 | 0.277 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.691565e-01 | 0.245 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.494737e-01 | 0.603 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.103826e-01 | 0.387 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.055577e-01 | 0.296 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.543027e-01 | 0.451 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.268737e-01 | 0.897 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.901558e-01 | 0.409 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.625327e-01 | 0.581 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.663031e-01 | 0.331 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.929983e-01 | 0.227 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.590099e-01 | 0.253 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.756124e-01 | 0.560 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.365158e-01 | 0.270 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.694067e-01 | 0.245 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.604145e-01 | 0.584 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.396345e-01 | 0.620 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.908043e-01 | 0.719 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.887047e-01 | 0.724 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 2.989046e-01 | 0.524 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.489297e-01 | 0.348 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.512207e-01 | 0.600 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.957414e-01 | 0.529 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.293106e-01 | 0.482 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.931677e-01 | 0.405 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.055577e-01 | 0.296 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 1.863022e-01 | 0.730 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.776021e-01 | 0.321 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 5.946700e-01 | 0.226 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.967517e-01 | 0.224 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.967517e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.000980e-01 | 0.222 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.000980e-01 | 0.222 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.000980e-01 | 0.222 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.002027e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.007847e-01 | 0.221 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.009994e-01 | 0.221 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.074915e-01 | 0.216 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.074915e-01 | 0.216 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.074915e-01 | 0.216 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.074915e-01 | 0.216 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.074915e-01 | 0.216 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.074915e-01 | 0.216 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 6.074915e-01 | 0.216 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.074915e-01 | 0.216 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.088185e-01 | 0.216 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.088185e-01 | 0.216 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.088185e-01 | 0.216 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.088185e-01 | 0.216 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 6.088185e-01 | 0.216 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.098844e-01 | 0.215 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.104462e-01 | 0.214 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.171226e-01 | 0.210 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.171226e-01 | 0.210 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.190930e-01 | 0.208 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.212793e-01 | 0.207 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.234553e-01 | 0.205 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 6.257870e-01 | 0.204 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.257870e-01 | 0.204 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.293327e-01 | 0.201 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.293327e-01 | 0.201 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 6.293327e-01 | 0.201 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.293327e-01 | 0.201 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.293327e-01 | 0.201 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.293327e-01 | 0.201 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.293327e-01 | 0.201 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.293327e-01 | 0.201 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.322678e-01 | 0.199 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.336308e-01 | 0.198 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 6.340683e-01 | 0.198 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.353676e-01 | 0.197 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.362675e-01 | 0.196 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.362675e-01 | 0.196 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.362675e-01 | 0.196 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.362675e-01 | 0.196 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.362675e-01 | 0.196 | 0 | 0 |
| Metabolism of vitamin K | R-HSA-6806664 | 6.362675e-01 | 0.196 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.362675e-01 | 0.196 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.362675e-01 | 0.196 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.362675e-01 | 0.196 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.362675e-01 | 0.196 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 6.375650e-01 | 0.195 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.375650e-01 | 0.195 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.375650e-01 | 0.195 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.375650e-01 | 0.195 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.388613e-01 | 0.195 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.410516e-01 | 0.193 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.435593e-01 | 0.191 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.435593e-01 | 0.191 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.435593e-01 | 0.191 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 6.435593e-01 | 0.191 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.435593e-01 | 0.191 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.438398e-01 | 0.191 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.480877e-01 | 0.188 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.488316e-01 | 0.188 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.497127e-01 | 0.187 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.547220e-01 | 0.184 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.547779e-01 | 0.184 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.558190e-01 | 0.183 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.568738e-01 | 0.183 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.568738e-01 | 0.183 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.568738e-01 | 0.183 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.568738e-01 | 0.183 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.568738e-01 | 0.183 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.568738e-01 | 0.183 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.568738e-01 | 0.183 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.568738e-01 | 0.183 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.568738e-01 | 0.183 | 0 | 0 |
| Translation | R-HSA-72766 | 6.616955e-01 | 0.179 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 6.617933e-01 | 0.179 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 6.625212e-01 | 0.179 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.659944e-01 | 0.177 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.676014e-01 | 0.175 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 6.702157e-01 | 0.174 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.702157e-01 | 0.174 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.749389e-01 | 0.171 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.749389e-01 | 0.171 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.749389e-01 | 0.171 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 6.749389e-01 | 0.171 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.749389e-01 | 0.171 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.749389e-01 | 0.171 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.749389e-01 | 0.171 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.749389e-01 | 0.171 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.749389e-01 | 0.171 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.749389e-01 | 0.171 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.749389e-01 | 0.171 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.749389e-01 | 0.171 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.749389e-01 | 0.171 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.749389e-01 | 0.171 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.749389e-01 | 0.171 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.755899e-01 | 0.170 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.755899e-01 | 0.170 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.755899e-01 | 0.170 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.755899e-01 | 0.170 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.755899e-01 | 0.170 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.761735e-01 | 0.170 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 6.761735e-01 | 0.170 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.774792e-01 | 0.169 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 6.774792e-01 | 0.169 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.774792e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.774792e-01 | 0.169 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.796605e-01 | 0.168 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.805524e-01 | 0.167 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.805524e-01 | 0.167 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.827509e-01 | 0.166 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.827509e-01 | 0.166 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 6.827509e-01 | 0.166 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.827509e-01 | 0.166 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.827509e-01 | 0.166 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.827509e-01 | 0.166 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 6.865360e-01 | 0.163 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.872302e-01 | 0.163 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.935302e-01 | 0.159 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.936079e-01 | 0.159 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.936079e-01 | 0.159 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.936079e-01 | 0.159 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.966232e-01 | 0.157 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.966232e-01 | 0.157 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.966232e-01 | 0.157 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.966232e-01 | 0.157 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 6.966232e-01 | 0.157 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.966232e-01 | 0.157 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.978656e-01 | 0.156 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.070064e-01 | 0.151 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.070064e-01 | 0.151 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.070064e-01 | 0.151 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.091746e-01 | 0.149 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.091746e-01 | 0.149 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.091746e-01 | 0.149 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.091746e-01 | 0.149 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.091746e-01 | 0.149 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.091746e-01 | 0.149 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.091746e-01 | 0.149 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.091746e-01 | 0.149 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.095009e-01 | 0.149 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.095009e-01 | 0.149 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.095009e-01 | 0.149 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.095009e-01 | 0.149 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.095009e-01 | 0.149 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.095009e-01 | 0.149 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 7.095009e-01 | 0.149 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.095009e-01 | 0.149 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.095009e-01 | 0.149 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.095009e-01 | 0.149 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 7.095009e-01 | 0.149 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.095009e-01 | 0.149 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.095009e-01 | 0.149 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 7.095009e-01 | 0.149 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.107508e-01 | 0.148 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.111073e-01 | 0.148 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.111073e-01 | 0.148 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 7.133308e-01 | 0.147 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 7.160782e-01 | 0.145 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.160782e-01 | 0.145 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.160782e-01 | 0.145 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.160782e-01 | 0.145 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.160782e-01 | 0.145 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.233892e-01 | 0.141 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 7.233892e-01 | 0.141 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 7.239548e-01 | 0.140 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 7.241771e-01 | 0.140 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.241771e-01 | 0.140 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.272530e-01 | 0.138 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.272530e-01 | 0.138 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.285051e-01 | 0.138 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.296927e-01 | 0.137 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.296927e-01 | 0.137 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.296927e-01 | 0.137 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.296927e-01 | 0.137 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.296927e-01 | 0.137 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.296927e-01 | 0.137 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.296927e-01 | 0.137 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.345519e-01 | 0.134 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.345519e-01 | 0.134 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.345519e-01 | 0.134 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.345519e-01 | 0.134 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.367396e-01 | 0.133 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.386156e-01 | 0.132 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.386156e-01 | 0.132 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.386156e-01 | 0.132 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.403899e-01 | 0.131 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.403899e-01 | 0.131 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.403899e-01 | 0.131 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.403899e-01 | 0.131 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.403899e-01 | 0.131 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.403899e-01 | 0.131 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.403899e-01 | 0.131 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.403899e-01 | 0.131 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.403899e-01 | 0.131 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.403899e-01 | 0.131 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.403899e-01 | 0.131 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.403899e-01 | 0.131 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.403899e-01 | 0.131 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.430416e-01 | 0.129 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.430416e-01 | 0.129 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.439639e-01 | 0.128 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.484062e-01 | 0.126 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.484599e-01 | 0.126 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 7.508690e-01 | 0.124 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.508690e-01 | 0.124 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 7.508690e-01 | 0.124 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.508690e-01 | 0.124 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 7.508690e-01 | 0.124 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.508690e-01 | 0.124 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.520624e-01 | 0.124 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.620455e-01 | 0.118 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.658120e-01 | 0.116 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.658120e-01 | 0.116 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.679961e-01 | 0.115 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.679961e-01 | 0.115 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.679961e-01 | 0.115 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.679961e-01 | 0.115 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 7.679961e-01 | 0.115 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.679961e-01 | 0.115 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.679961e-01 | 0.115 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 7.679961e-01 | 0.115 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.679961e-01 | 0.115 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.686318e-01 | 0.114 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.706001e-01 | 0.113 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.706001e-01 | 0.113 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.706210e-01 | 0.113 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.713785e-01 | 0.113 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 7.725123e-01 | 0.112 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.740058e-01 | 0.111 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.785807e-01 | 0.109 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.822470e-01 | 0.107 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.842857e-01 | 0.106 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.855096e-01 | 0.105 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.862178e-01 | 0.104 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.862178e-01 | 0.104 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.862178e-01 | 0.104 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 7.889536e-01 | 0.103 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.889536e-01 | 0.103 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 7.889536e-01 | 0.103 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.889536e-01 | 0.103 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.889536e-01 | 0.103 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.893915e-01 | 0.103 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.908063e-01 | 0.102 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.915408e-01 | 0.102 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.926681e-01 | 0.101 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.926681e-01 | 0.101 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.926681e-01 | 0.101 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.926681e-01 | 0.101 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.926681e-01 | 0.101 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.926681e-01 | 0.101 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.926681e-01 | 0.101 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.926681e-01 | 0.101 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.926681e-01 | 0.101 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.926681e-01 | 0.101 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.926681e-01 | 0.101 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 7.926681e-01 | 0.101 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.926681e-01 | 0.101 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.926681e-01 | 0.101 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.926681e-01 | 0.101 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.926681e-01 | 0.101 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.926681e-01 | 0.101 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.965627e-01 | 0.099 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.990525e-01 | 0.097 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.990525e-01 | 0.097 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.992560e-01 | 0.097 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.999621e-01 | 0.097 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.024981e-01 | 0.096 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.024981e-01 | 0.096 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.025741e-01 | 0.096 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.059995e-01 | 0.094 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.059995e-01 | 0.094 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.071715e-01 | 0.093 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.079091e-01 | 0.093 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.116434e-01 | 0.091 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.129625e-01 | 0.090 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.129625e-01 | 0.090 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.136669e-01 | 0.090 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.147178e-01 | 0.089 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 8.147178e-01 | 0.089 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.147178e-01 | 0.089 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.147178e-01 | 0.089 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.147178e-01 | 0.089 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.147178e-01 | 0.089 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.147178e-01 | 0.089 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 8.147178e-01 | 0.089 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.147178e-01 | 0.089 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.147178e-01 | 0.089 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 8.147178e-01 | 0.089 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.147178e-01 | 0.089 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.147178e-01 | 0.089 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.173436e-01 | 0.088 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.218081e-01 | 0.085 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.218081e-01 | 0.085 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.218081e-01 | 0.085 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.218081e-01 | 0.085 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.218081e-01 | 0.085 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.243242e-01 | 0.084 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.260476e-01 | 0.083 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 8.271079e-01 | 0.082 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.271079e-01 | 0.082 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.344236e-01 | 0.079 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 8.344236e-01 | 0.079 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.344236e-01 | 0.079 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.344236e-01 | 0.079 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.344236e-01 | 0.079 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.344236e-01 | 0.079 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.344236e-01 | 0.079 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.344236e-01 | 0.079 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.344236e-01 | 0.079 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.344236e-01 | 0.079 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.344236e-01 | 0.079 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.344236e-01 | 0.079 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.344236e-01 | 0.079 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.344236e-01 | 0.079 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.344236e-01 | 0.079 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.344236e-01 | 0.079 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 8.344236e-01 | 0.079 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.344236e-01 | 0.079 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.344236e-01 | 0.079 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.344827e-01 | 0.079 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.345392e-01 | 0.079 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.345392e-01 | 0.079 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.345392e-01 | 0.079 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.364499e-01 | 0.078 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.364499e-01 | 0.078 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 8.364499e-01 | 0.078 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.364499e-01 | 0.078 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.364499e-01 | 0.078 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.364499e-01 | 0.078 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.364499e-01 | 0.078 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.368212e-01 | 0.077 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.383409e-01 | 0.077 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.383409e-01 | 0.077 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.383409e-01 | 0.077 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.383409e-01 | 0.077 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.394541e-01 | 0.076 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.409163e-01 | 0.075 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.409722e-01 | 0.075 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.441557e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.441557e-01 | 0.074 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.441557e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.444250e-01 | 0.073 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.450867e-01 | 0.073 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.454774e-01 | 0.073 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.491594e-01 | 0.071 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.498761e-01 | 0.071 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.498761e-01 | 0.071 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.498761e-01 | 0.071 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.498761e-01 | 0.071 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.499940e-01 | 0.071 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.499940e-01 | 0.071 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.499940e-01 | 0.071 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.502968e-01 | 0.070 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.520346e-01 | 0.070 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.520346e-01 | 0.070 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.520346e-01 | 0.070 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.520346e-01 | 0.070 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.524926e-01 | 0.069 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.533573e-01 | 0.069 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.538429e-01 | 0.069 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.550612e-01 | 0.068 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 8.581170e-01 | 0.066 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.581917e-01 | 0.066 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.606874e-01 | 0.065 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.606874e-01 | 0.065 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.606874e-01 | 0.065 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.608283e-01 | 0.065 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.612463e-01 | 0.065 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.612463e-01 | 0.065 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.612463e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.612463e-01 | 0.065 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.612463e-01 | 0.065 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.621018e-01 | 0.064 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.621018e-01 | 0.064 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.625084e-01 | 0.064 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 8.625084e-01 | 0.064 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.625084e-01 | 0.064 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.625084e-01 | 0.064 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.631973e-01 | 0.064 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 8.644840e-01 | 0.063 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.652724e-01 | 0.063 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.677735e-01 | 0.062 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.677735e-01 | 0.062 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.677735e-01 | 0.062 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.677735e-01 | 0.062 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 8.677735e-01 | 0.062 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.677735e-01 | 0.062 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.677735e-01 | 0.062 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.677735e-01 | 0.062 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.677735e-01 | 0.062 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.677735e-01 | 0.062 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.681144e-01 | 0.061 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.691631e-01 | 0.061 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.697198e-01 | 0.061 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.697198e-01 | 0.061 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.704043e-01 | 0.060 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.704043e-01 | 0.060 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.708089e-01 | 0.060 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.708089e-01 | 0.060 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.708089e-01 | 0.060 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.708089e-01 | 0.060 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.717202e-01 | 0.060 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.720630e-01 | 0.059 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 8.740588e-01 | 0.058 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.740588e-01 | 0.058 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.740588e-01 | 0.058 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.742631e-01 | 0.058 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.768405e-01 | 0.057 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.768405e-01 | 0.057 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.771034e-01 | 0.057 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.771034e-01 | 0.057 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.802745e-01 | 0.055 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.817604e-01 | 0.055 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.818390e-01 | 0.055 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.818390e-01 | 0.055 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.818390e-01 | 0.055 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.818390e-01 | 0.055 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.818390e-01 | 0.055 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.818390e-01 | 0.055 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.818390e-01 | 0.055 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.818390e-01 | 0.055 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 8.818390e-01 | 0.055 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.818390e-01 | 0.055 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.818390e-01 | 0.055 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.818390e-01 | 0.055 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.841323e-01 | 0.053 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 8.847086e-01 | 0.053 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.847086e-01 | 0.053 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.847086e-01 | 0.053 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.847086e-01 | 0.053 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.847086e-01 | 0.053 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.847086e-01 | 0.053 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.848031e-01 | 0.053 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.857439e-01 | 0.053 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.857439e-01 | 0.053 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.857439e-01 | 0.053 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.891177e-01 | 0.051 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.891177e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.891177e-01 | 0.051 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.928117e-01 | 0.049 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.928117e-01 | 0.049 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.935079e-01 | 0.049 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.944091e-01 | 0.048 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.944091e-01 | 0.048 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.944091e-01 | 0.048 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.944091e-01 | 0.048 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 8.944091e-01 | 0.048 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.944091e-01 | 0.048 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.944091e-01 | 0.048 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.944091e-01 | 0.048 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.944091e-01 | 0.048 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.944091e-01 | 0.048 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.944091e-01 | 0.048 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.944091e-01 | 0.048 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.945187e-01 | 0.048 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 8.945187e-01 | 0.048 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.945187e-01 | 0.048 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.945187e-01 | 0.048 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.962767e-01 | 0.048 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.970884e-01 | 0.047 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.970884e-01 | 0.047 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.973714e-01 | 0.047 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 8.973714e-01 | 0.047 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.019241e-01 | 0.045 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.024876e-01 | 0.045 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.024876e-01 | 0.045 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.032085e-01 | 0.044 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 9.035471e-01 | 0.044 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.035471e-01 | 0.044 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 9.035471e-01 | 0.044 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.035471e-01 | 0.044 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.035471e-01 | 0.044 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.040754e-01 | 0.044 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.050677e-01 | 0.043 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.050677e-01 | 0.043 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 9.056426e-01 | 0.043 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.056426e-01 | 0.043 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.056426e-01 | 0.043 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.056426e-01 | 0.043 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.056426e-01 | 0.043 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 9.056426e-01 | 0.043 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 9.056426e-01 | 0.043 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.056426e-01 | 0.043 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.102224e-01 | 0.041 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.118492e-01 | 0.040 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.118492e-01 | 0.040 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.118492e-01 | 0.040 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.118492e-01 | 0.040 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.121021e-01 | 0.040 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.121021e-01 | 0.040 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.122379e-01 | 0.040 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.122379e-01 | 0.040 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.122379e-01 | 0.040 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.122379e-01 | 0.040 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.122379e-01 | 0.040 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.137664e-01 | 0.039 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.137664e-01 | 0.039 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.137664e-01 | 0.039 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.143684e-01 | 0.039 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.146207e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.156816e-01 | 0.038 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.156816e-01 | 0.038 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.156816e-01 | 0.038 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.156816e-01 | 0.038 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.156816e-01 | 0.038 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.156816e-01 | 0.038 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.156816e-01 | 0.038 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.189024e-01 | 0.037 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.194771e-01 | 0.036 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.210512e-01 | 0.036 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.227456e-01 | 0.035 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.246530e-01 | 0.034 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 9.246530e-01 | 0.034 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.246530e-01 | 0.034 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.246530e-01 | 0.034 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.246530e-01 | 0.034 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.246530e-01 | 0.034 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.246530e-01 | 0.034 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.251197e-01 | 0.034 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.251197e-01 | 0.034 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.251892e-01 | 0.034 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.264804e-01 | 0.033 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.268586e-01 | 0.033 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.277564e-01 | 0.033 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.290306e-01 | 0.032 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.290306e-01 | 0.032 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.291392e-01 | 0.032 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.308885e-01 | 0.031 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.326704e-01 | 0.030 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.326704e-01 | 0.030 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.326704e-01 | 0.030 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.326704e-01 | 0.030 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.326704e-01 | 0.030 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.329056e-01 | 0.030 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 9.329056e-01 | 0.030 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.361511e-01 | 0.029 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.362457e-01 | 0.029 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.364798e-01 | 0.029 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.364798e-01 | 0.029 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.364798e-01 | 0.029 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 9.369175e-01 | 0.028 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.369175e-01 | 0.028 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.374934e-01 | 0.028 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.381474e-01 | 0.028 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.387964e-01 | 0.027 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.387964e-01 | 0.027 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.387964e-01 | 0.027 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.387964e-01 | 0.027 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.393479e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.394406e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.394406e-01 | 0.027 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.398350e-01 | 0.027 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.398350e-01 | 0.027 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.398350e-01 | 0.027 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.398350e-01 | 0.027 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.398350e-01 | 0.027 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.398350e-01 | 0.027 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.398350e-01 | 0.027 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.398350e-01 | 0.027 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.398350e-01 | 0.027 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.398350e-01 | 0.027 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.399252e-01 | 0.027 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.422463e-01 | 0.026 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.422463e-01 | 0.026 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 9.441937e-01 | 0.025 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.441937e-01 | 0.025 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.441937e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 9.450220e-01 | 0.025 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.458265e-01 | 0.024 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.459865e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.459865e-01 | 0.024 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.462377e-01 | 0.024 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.462377e-01 | 0.024 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.462377e-01 | 0.024 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.462377e-01 | 0.024 | 0 | 0 |
| Abacavir metabolism | R-HSA-2161541 | 9.462377e-01 | 0.024 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.462922e-01 | 0.024 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.463928e-01 | 0.024 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.491358e-01 | 0.023 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.491358e-01 | 0.023 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.491358e-01 | 0.023 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.500981e-01 | 0.022 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.502650e-01 | 0.022 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.518069e-01 | 0.021 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.519593e-01 | 0.021 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.519593e-01 | 0.021 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.519593e-01 | 0.021 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.519593e-01 | 0.021 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.519593e-01 | 0.021 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 9.519593e-01 | 0.021 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.519593e-01 | 0.021 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.525580e-01 | 0.021 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.525580e-01 | 0.021 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.536585e-01 | 0.021 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.536585e-01 | 0.021 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.537682e-01 | 0.021 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.538786e-01 | 0.021 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.539537e-01 | 0.020 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.570723e-01 | 0.019 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.570723e-01 | 0.019 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.570723e-01 | 0.019 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.570723e-01 | 0.019 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.570723e-01 | 0.019 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.570723e-01 | 0.019 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.570723e-01 | 0.019 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.570723e-01 | 0.019 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.575952e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.577148e-01 | 0.019 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.579376e-01 | 0.019 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.580763e-01 | 0.019 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.586277e-01 | 0.018 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.598792e-01 | 0.018 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.603904e-01 | 0.018 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.603904e-01 | 0.018 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.611007e-01 | 0.017 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.611007e-01 | 0.017 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.616414e-01 | 0.017 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.616414e-01 | 0.017 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.616414e-01 | 0.017 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.616414e-01 | 0.017 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.616414e-01 | 0.017 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.619377e-01 | 0.017 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.631029e-01 | 0.016 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.639952e-01 | 0.016 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.642306e-01 | 0.016 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.657244e-01 | 0.015 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.657244e-01 | 0.015 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.657244e-01 | 0.015 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.657244e-01 | 0.015 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.657244e-01 | 0.015 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.657244e-01 | 0.015 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.657244e-01 | 0.015 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.671220e-01 | 0.015 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.681860e-01 | 0.014 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.681860e-01 | 0.014 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.681860e-01 | 0.014 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.681860e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.693731e-01 | 0.014 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.693731e-01 | 0.014 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.693731e-01 | 0.014 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.693731e-01 | 0.014 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.693731e-01 | 0.014 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.693731e-01 | 0.014 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.694998e-01 | 0.013 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.697917e-01 | 0.013 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.699598e-01 | 0.013 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.699960e-01 | 0.013 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.710657e-01 | 0.013 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.719180e-01 | 0.012 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.719180e-01 | 0.012 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.722553e-01 | 0.012 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.726335e-01 | 0.012 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.726335e-01 | 0.012 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.726335e-01 | 0.012 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.726335e-01 | 0.012 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.726335e-01 | 0.012 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.736931e-01 | 0.012 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.736931e-01 | 0.012 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.737971e-01 | 0.012 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.749609e-01 | 0.011 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.755470e-01 | 0.011 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.755470e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.755470e-01 | 0.011 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.755470e-01 | 0.011 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.755470e-01 | 0.011 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.755594e-01 | 0.011 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.760892e-01 | 0.011 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.760892e-01 | 0.011 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.767900e-01 | 0.010 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.770504e-01 | 0.010 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.781504e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.781504e-01 | 0.010 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.781504e-01 | 0.010 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.788045e-01 | 0.009 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.797290e-01 | 0.009 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.798089e-01 | 0.009 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.803302e-01 | 0.009 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.804769e-01 | 0.009 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.804769e-01 | 0.009 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.804769e-01 | 0.009 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.812571e-01 | 0.008 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.813708e-01 | 0.008 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.819667e-01 | 0.008 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.819667e-01 | 0.008 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.825557e-01 | 0.008 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.833383e-01 | 0.007 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.837277e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.837277e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.837277e-01 | 0.007 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.844133e-01 | 0.007 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.844133e-01 | 0.007 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.844133e-01 | 0.007 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.844133e-01 | 0.007 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.859850e-01 | 0.006 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.860732e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.860732e-01 | 0.006 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.860732e-01 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.861726e-01 | 0.006 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.862933e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.869424e-01 | 0.006 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.869424e-01 | 0.006 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.869424e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.888817e-01 | 0.005 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.888817e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.888817e-01 | 0.005 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.897964e-01 | 0.004 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.900659e-01 | 0.004 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.900659e-01 | 0.004 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.900659e-01 | 0.004 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.900659e-01 | 0.004 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.902623e-01 | 0.004 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.910688e-01 | 0.004 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.911241e-01 | 0.004 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.911241e-01 | 0.004 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.917829e-01 | 0.004 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.918322e-01 | 0.004 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.918693e-01 | 0.004 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.920696e-01 | 0.003 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.920696e-01 | 0.003 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.920696e-01 | 0.003 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.920696e-01 | 0.003 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.923365e-01 | 0.003 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.925623e-01 | 0.003 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.926456e-01 | 0.003 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.928705e-01 | 0.003 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.929144e-01 | 0.003 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.929144e-01 | 0.003 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.929144e-01 | 0.003 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.929144e-01 | 0.003 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.932032e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.936693e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.936693e-01 | 0.003 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.936693e-01 | 0.003 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.936693e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.938193e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.943438e-01 | 0.002 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.943438e-01 | 0.002 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.949465e-01 | 0.002 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.949465e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.952723e-01 | 0.002 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.954633e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.954850e-01 | 0.002 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.954850e-01 | 0.002 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.958936e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.962838e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.963373e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.963960e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.964081e-01 | 0.002 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.967801e-01 | 0.001 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.967801e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.969063e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.971233e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.971233e-01 | 0.001 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.971233e-01 | 0.001 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.971233e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.972821e-01 | 0.001 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.975188e-01 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.977038e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.977378e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.981283e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.981283e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.981524e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.981673e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.983627e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.983627e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.984910e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.985373e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.986397e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.986427e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.986427e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.986932e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.987377e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.987737e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.988922e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.989138e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.989315e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.990661e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.991496e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.991591e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.992564e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.993997e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994362e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.995061e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995110e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.995574e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.996624e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.996925e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997340e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.997458e-01 | 0.000 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.997851e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997851e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998314e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998375e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998401e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998632e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998632e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.999025e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999159e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999242e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999385e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999425e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999482e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999519e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999528e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999567e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999665e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999676e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999749e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999781e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999799e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999822e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999826e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999847e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999854e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999868e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999902e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999913e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999915e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999925e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999942e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999956e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999957e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999959e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999960e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999968e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999978e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999978e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999989e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999989e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999991e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999994e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999998e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |